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ABSTRACT
Irogesteronei

Inhibition of Female Rat Sexual Behavior

And Investigations of Its Mechanism of Action
(September 197?)

-

Jeffrey D. Blaustein, B.S., University of Massachusetts
M.S., University of Massachusetts
Ph.D., University of Massachusetts

Directed by:

Professor George N. Wade

Chronic injections of high doses of progesterone (5 mg) and

low doses of estradiol benzoate (EB; 2 ug) resulted in less sexual
behavior than low doses of progesterone (0.5 mg) and low doses of
EB.

In a typical procedure for inducing sexual behavior, EB

progesterone were given sequentially, separated by ^2 hours.

and.

High

levels of progesterone (2.5 and 5 mg) administered, concurrently with
EB inhibited, the induction of sexual receptivity (concurrent inhibition).

Increasing the dose of EB from 2 ug to 6 ug

offset this inhibition.

otr

10 ug

High doses of progesterone (5 mg) admin-

istered, simultaneously, or 2 to 16 hours prior to EB, inhibited, the

induction of sexual behavior, but the inhibition was less if progesterone was administered. 48 hours prior to EB.

A single injection of

progesterone (l mg) that does not inhibit the induction of sexual
behavior when administered concurrently with EB inhibited, lordosis
if distributed, into five injections (0.2 mg) every 4 hours.

When a large dose of progesterone was administered, to

ectomized rats 2k hours after a 2

;ug

oveiri-

injection of estradiol

benzoate, sexual receptivity was inhibited. 30 hours later (sequential

inhibition).

Larger doses of progesterone (l mg) were required to

V

inhibit the induction of sexual receptivity when
tested

after

^

hours

administration than were necessary to facilitate sexual

behavior 30 hours after EB.

This inhibition was not due to copulatory

stimuli from the first test, because inhibition occurred,
even if the
first test was omitted..

The degree of inhibition of sexual behavior

produced, by progesterone was dose dependent on estradiol;
increasing

the EB priming dose offset the inhibition caused by 1 mg of progesterone.

The results of two experiments in which progesterone did not
inhibit the uptake or retention of -^H-estradiol by brain cell nuclei
suggest that the antiestrogenic action of progesterone in the central

nervous system is not
diol.

d.ue

to interference with the binding of estra-

The results of an experiment which dissociated behaviorally

the antiestrogenic action of progesterone from that of a synthetic

antiestrogen, CI-628, are consistent with the notion that progesterone

and synthetic estrogen antagonists inhibit the behavioral effects of
estradiol by separate mechanisms.

A synthetic progestin,

17<<,

21-dimethyl-19-nar-pregna-4,9-

diene-3,20-dione (R5020), was 5O-IOO times as effective as progesterone in facilitating (5
vs. 1,000

;ug)

and.

>u€

vs. 250 ;ug), sequentially inhibiting (10

concurrently inhibiting (50 v% vs. 2,500

female sexual behavior in ovariectomized rats.

yUg

jig)

This progestin, which

binds to mammalian uterine progestin receptors with higher affinity
than progesterone, is bound, in vivo by cell nuclei from uterus,

pituitary, hypothalamus, preoptic area - septum and cortex of ovariectomized-adrenalectomized. rats.

Binding is dependent on estrogen

pretreatmenti it is saturable (suppressed more by pretreatment with

vi

R 5020 or prog.-sterone than by corticosterone or
testostetrone)

The

li.zk of

binding after ^H-progesterone injection is attributed

to the more rapid dissociation of progesterone from
its receptor.

These studies support the hypothesis that binding of progestins
by
brain cell nuclei may be a prerequisite for at least some
behavioral

responses to progestins.
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INIRODUCTION

Progestins antagonize and facilitate the effects
of estradiol
on various behaviors.

Progestins have no apparent behavioral

effects. that do not require an interaction with
estrogens (Feder

& Marrone, 1977; Morin, 1977).

The facilitatory effect of proges-

terone after estrogen priming on female sexual behavior
has been
observed, in guinea pigs (Collins, Boling Dempsey & Young,
I938),

rats (Beach, 19^2; Boling & Blandau, 1939) and hamsters (Carter &
Porges, 197^, Frank & Fraps, 19^5).

Although sexual behavior can be induced, in ovariectomized (OVX)
rodents by estrogens alone (guinea pigs:
1938; Dempsey, Hertz & Young, I936, rats:

Boling, Young & Dempsey,

Davidson, Smith, Rodgers

& Block, 1968; Edwards, Whalen & Nadler, I968; Green, Luttge &
Whalen, 1970; hamsters:

Carter, Michael & Morris, 1973), progestins'

involvement in the induction of sexual behavior during the estrous
cycle is obligatory.

By ovariectomizing at a time which prevents the

preovulatory progesterone surge (Croix & Pranchimont, 1975; Feder,

Resko & Goy, I968; Butcher, Collins & Fugo, 1974; Lukaszewska &
Greenwald., 1970), it has been demonstrated, that endogenous estrogen

is not sufficient to induce sexual receptivity in guinea pigs (Joslyn,
Fed.ea:,

& Goy, 1971) » rats (Powers, 1970) or hamsters (Ciaccio &

Llsk, 1971).

In estrous cycling rodents, the induction of sexual

behavior requires not only estrogen priming, but also a subsequent
surge of progesterone from either an exogenous or endogenous source.

The use of ovariectomized rodents with sexual behavior induced

by controlled, doses of hormone enables more complex interactions

2

of estrogens

and.

progestins to be investigated and parcelled
out.

For example, when progesterone is administered
at various intervals
after a sufficient dose of an estrogen, heat occurs
with shorter

latency with a more discrete duration and in a larger
percentage of
guinea pigs than with estrogen-induced, heat (Collins et al.,
I938;
Young, 1969; Zucker & Goy, I967).

The addition of progesterone

also results in a more consistent latency to heat and in an
increase
in the duration that the lordosis posture is held (Zucker & Goy,
1967),

Increasing doses of progesterone may increase the duration

of heat in guinea pigs (Joslyn et al., I97I; but cf. Dempsey et al.,
1936).

Heat terminates despite high plasma levels of progesterone

(Morin & Fed.er, 1973).

Thus, progesterone seems to increase heat

duration, but it also causes its termination.

In experiments with rats, measurements do not usually include

latency to onset of sexual receptivity or its duration, since sexual

receptivity changes
1972).

£ls

a result of repeated, testing (Hardy & DeBold,

Nevertheless, the percentage of rats that become sexually

receptive when estrogen is followed, by progesterone is greater than
with estrogen alone (Beach, 19^2; Boling & Blandau, 1939).

The role of progesterone in the induction of sexual behavior
in the golden hamster appears to be no different than in guinea pigs

or rats.

Whereas estradiol alone is followed, by estrous behavior

in only a few percent of ovariectomized hamsters, if sufficient

quantities of progesterone are administered. 24-48 hours after estradiol, all or nearly all of the females become sexually receptive

(Frank & Fraps, 1945).

As with guinea pigs, a progesterone injection

increases lordosis duration and decreaLses the latent period in

3

hamsters administered, daily injections of estradiol
.

When a single

estrogen injection is followed by a single
progesterone injection,

increasing doses of progesterone result in an increase
in the per-

entage of hamsters in heat and in the lordosis duration
during a test
(Caxter & Forges, 1974),

Besides facilitating the actions of estrogens in the induction
of sexual receptivity, progesterone is the most potent naturally-

occurring antiestrogen.

In I936, Dempsey, Hertz & Young first sug-

gested, "the presence of a functional corpus luteum.

.

.might counteract

the effect of (estradiol)" on the induction of sexual behavior in
female guinea pigs.

When sufficient levels of progesterone are

present during the time of estrogen conditioning''", the induction of
sexual behavior is inhibited,
Moreines, 1976).

(

concurrent inhibition

.

Powers &

Concurrent inhibition has been distinguished, from sequen-

tial inhibition which occurs subsequent to the completion of estrogen

conditioning

of sexual receptivity.

The role of progesterone in the inhibition of sexual behavior
has been well-documented, for guinea pigs (Goy & Phoenix, 1965;
Wallen, Goy & Phoenix, 1975; Zucker, I966; Zucker & Goy, I967).
In intact guinea pigs, a substance of ovarian origin, presumably

progesterone, has a transient concurrent inhibitiory influence on the

induction of sexual receptivity.

Goy et al.

,

(I966) have shown that

estradiol benzoate progesterone induction of sexual receptivity

1

Estrogen "conditioning" is shorthand and. refers to the changing state
of the central nervous system substrate. It is considered to be
complete when a progesterone injection will induce sexual behavior.

is Inhibited during the luteal phase
of the guinea pig estrous
cycle.

If they attempted, to induce heat during
most stages of

pregnancy, no lordosis was ohserved (Goy et
al., I966).

When guinea

pigs were administered EB + progesterone beginning
on Bay 9 of the
estrous cycle, generally none or few of the animals
became sexually

receptive (Goy et al., I966; Zucker, I968).

If, however, the animals

were ovariectomized. at either the time of, 12 hours,
or 18 hours after

the EB injection, neaxly all of the animals became receptive.

When

ovariectomy was performed Zk or 36 hours after EB, sexual receptivity
was inhibited (Zucker, I968).

When ovariectomized, guinea pigs received an injection of progesterone two hours prior to 6

;ug

of estradiol benzoate, the percentage

of animals becoming sexually receptive following a second injection

of progesterone 36 hours later was inversely related, to the dose of

the first (inhibitory) injection; 0.5 mg was adequate to inhibit
sexual receptivity in all animals (Goy & Phoenix, I965; Wallen et al.
1975).

One mg of progesterone administered either six hours after

estradiol benzoate or up to 2^ hours prior to the estradiol benzoate,

inhibited the induction of sexual behavior when tested after an
additional progesterone injection 36 hours later (Wallen et al.
Zucker, I966).

The progesterone injection decreased, the percentage

of guinea pigs becaning sexually receptive, slightly increased the

latency to lordosis and also decreased, the duration of heat when
compared, with animals that either received, no concurrent proges-

terone or received, it 48 or 72 hours prior to estradiol.
The results of Wallen et al., (1975) clearly demonstrate that

the interval, between progesterone and estradiol is critical in

5

inhibiting sexual behavior.

If the progesterone injection precedes

the estradiol injection by too long a duration, inhibition is not
observed.

In fact, using supporting radioimmunoassay data of blood

progesterone levels following subcutaneous progesterone injections,
they suggest that the inhibition is directly related to blood

plasma progesterone concentrations.

A similar temporal dependence

of inhibition on progesterone has also been demonstrated in intact

guinea pigs by Zucker (I966).
Relatively little is known of progesterone 's inhibitory effects
on sexual behavior in rats.

In retrospect, the originally reported

failure to inhibit sexual behavior in ovariectomized rats with
injections of either 0,l6 mg or

1

mg of progesterone given simul-

taneously with, or twelve hours subsequent to injections of 6 Mg of
Edwards,

estradiol benzoate is not surprising (Zucker, 1967a).

Whalen & Nadler (I968) found that 5 ug EB + O.5 mg progesterone

daily for ten days induced high levels of receptivity as measured on
the tenth day of treatment.

On the contrary, 5 wg EB + 5 mg of

progesterone induced levels approximately

50?^

that of the group
Thus, inhibition

that received low levels (0.5 mg) of progesterone.

in rats seems to depend on high doses of progesterone.

When Powers and Zucker (1969) attempted to induce sexual behavior during pregnancy and pseud ©pregnancy with estradiol benzoate,

they obtained indirect evidence that suggested that high levels of
progesterone may be required to concurrently inhibit sexual behavior.
later
During pregnancy, EB was injected and followed 24 or 48 hours

by testing for sexual behavior (Powers & Zucker, I969).

EB induced sexual behavior if administered on Day

0,

Two wg of

but not if

injected on Days 3-15 of pregnancy.

On the .ther hand. 6

of EB

induced low levels if administered
on Day 5, moderately high levels
if administered on Day 10 but did
not induce heat if administered
on Day I5.

Since it is known that plasma progesterone
levels first

exceed estrous-cycle levels on Days 2-5 of
pregnancy and peak at
around Day I5 (Fajer & Barraclough,
196?; Hashimoto. Henricks.

Anderson & Melampy. I968). this suggested that
progesterone may be
causing inhibition of sexual behavior induced by EB.

Even more

striking, however, is the demonstration that 6
ug of EB can induce

sexual behavior at times at which 2

of EB cannot, demonstrating

a dose dependency on estradiol as well as the indirect
suggestion of

dose dependency on progesterone.
00UIS8,

This latter dependency is, of

purely correlational and is simply based on the fact that

inhibition correlates with progesterone levels.

The same relation-

ships were obtained, on the corresponding days of pseud opregnancy.
Thus, assuming that progesterone is responsible for the inhibition

during pregnancy, relatively low levels of progesterone can inhibit
the induction of heat with low doses of EB, but higher doses of EB
can offset this inhibition; high levels of progesterone can inhibit
even higher doses of EB, at least up to the 6 Mg of EB used in this
experiment.

These studies therefore, raise the possibility that in-

hibition of sexual receptivity in rats by progesterone may be
critically dependent on the relative doses of progesterone and estradiol benzoate administered.

Following the period of sexual receptivity, a refractory period
ensues in guinea pigs during which a subsequent injection of proges-

terone does not facilitate another episode of sexual behavior

(Bollng, Young i Dempsey, I938).

This period, which is of variable

duration, can be influenced by the
progesterone dose (Wallen, Goy
tc

Phoenix, 1975; Zucker, I966; Zucker & Goy, I967),
additional

estradiol administered (Zucker, I966) and the
interval between the
first and second progesterone injection (Zucker,
I966).

This type

of inhibition has been referred to as sequential
inhibition

.

Boling

et al. (1938) first demonstrated that following the
induction of

heat by estradiol benzoate + progesterone, a second
injection of

progesterone does not reinduce sexual receptivity, although
sexual

receptivity can be induced if the first progesterone injection
is

omitted (Collins, Boling, Dempsey & Young, I938).

Following

termination of estrogen-induced heat, however, progesterone did
induct a second period of sexual receptivity, thus demonstrating
that it is not sexual receptivity

2^

se,

hut progesterone that

inhibits reinduction of sexual behavior.

In subsequent work with ovariectomized guinea pigs (Zucker,
1966) sexual receptivity was first induced by estrogen + progesterone.

At various time intervals after this progesterone injection, a
second progesterone injection was administered.

As the latency to

the second progesterone injection increased from 12 to 171 hours,
there was a tendency for more frequent recurrence of heat, but even
at 171 hours, only one- third of the guinea pigs became receptive.

It has recently been demonstrated that inhibition of sexual

behavior can occur without prior facilitation.
were primed with 3»3

When guinea pigs

of estradiol benzoate and tested for sexual

receptivity with only 15 Ug of progesterone at 36 hours, the lordosis
of

65?^

of the guinea pigs was inhibitied when tested with 0.6 mg of

progesterone at 60 hours (Morin & Feder,
1974a).

In a further

analysis it was shown that of the animals that
were not receptive
in the first test, only

20fo

of them responded on the second; of

the animals which were receptive on the first
test,
on the second test.

50?S

responded

This is accepted as evidence that a lower
dose

of progesterone is required for inhibition than
facilitation with

this procedure.

It is obvious that this particular set of results

is probably critically dependent on the interval between
progesterone

injections (cf. Zucker, I966).

Presumably, if Morin and Feder (1974)

had waited longer than 60 hours for the second progesterone
injection

and test, a greater quantity of progesterone would have been required for inhibition.

Boling et al. (1938) had initially demonstrated that following
EB + progesterone induction of heat, guinea pigs can readily be
induced, to exhibit a second episode of receptivity if EB is ad-

ministered prior to the second progesterone injection.

Actually

most of their guinea pigs could be brought into four or five separate
episodes in fifteen days if the sexual behavior was induced by EB +
progesterone.

Using different doses of hormones than in previous

work, Zucker (1966; 6

jjg

EB + 0.4 mg progesterone) was capable of

reinducing sexuaJ. receptivity if the latency from the first progesterone injection to the second estradiol injection was of long
enough duration.

As the latency increased from 6 hours to I5 hours

to 58 hours, increasing numbers of the guinea pigs became sexually

receptive, and maocimum lordosis duration increased.

The refractory period depends on adequate dose of progesterone
for the first progestin injection.

As the dose of the first

8

progesterone injection increases, fewer anim-.ls become receptive

following a second progesterone injection (Zucker & Goy, I968; Goy

Wallen^al.,

& Phoenix, I965;

1975).

The results of Boling et al. (1938) that had shown that guinea
pigs could be repeatedly brought into heat by EB + progesterone are
consistent with those of Zucker (I966) and Zucker & Goy (196?)
that had shown that under some circumstances, guinea pigs could be

successively brought into heat and under some circumstances they
could not.

Taking into consideration the dose dependency of the

inhibition on progesterone (Goy & Phoenix, 1965; Wallen et al., 1975;

Zucker & Goy, I967) and the temporal dependence of the progesterone

and estradiol injections

(Zucker, 1966), it becomes obvious that if

a wide range of hormone dosages are not tried, contradictory results
can readily be obtained.

This fact may well account for the early

conflicting findings in rats.

As was the case with concurrent inhibition, first attempts to
obtain sequential inhibition in ovariectoraized rats were unsuccessful
(Zucker, 1967a).

Ovariectomized rats were injected with 6 pg EB

followed at 36 hours with 0.^ mg of progesterone.

Most of the rats

EB.
were sexually receptive when they were tested k2\ hours after

again
Sixty hours after the initial EB injection progesterone was
administered..

This resulted in lordosis qubtients which were not

significantly lower

thain

those obtained on the first test.

The

and were
results were different from those obtained in guinea pigs

administered prounexpected in light of the fact that exogenously
estrous cycle in
gesterone inhibits sexual receptivity during the

rats (Zucker, 1967b).

Progesterone administered on any of the first

10

three days of

-^he

four-day estrous cycle delayed, the occurrence of

sexual behavior (Zucker, 1967b),

In Zucker 's attempt to obtain progesterone-induced sequential

inhibition in ovariectomized. rats, doses of estradiol and proges-

terone were chosen which were known to be effective in guinea pigs
(Zucker, 1967a).

However, rats

responsiveness to progesterone

suid

guinea pigs differ in their

(WsuJe et al.,

Specifically,

1973).

rats are less sensitive to progesterone than guinea pigs in the
facilitation of sexual behavior (Powers & Valenstein, 1972; Wade

& Feder, 1972), and perhaps more sensitive to estradiol than

guinea pigs (Boling & Blandau, 1939; Dempsey et al.

,

I936).

Nadler

(1970) attempted to induce a refractory period in ovariectomized rats

using smaller quantities of estradiol benzoate than

ously used.

At 48 hours, oil or 0.5 mg of progesterone was

administered, and. rats tested, for receptivity.
rog

been previ-

One microgram of estradiol benzoate was injected at

both 0 and. 2k hours.

0.5

had.

A day later (72 hours)

of progesterone was administered and. rats were tested again

for receptivity.

In this situation, the second progesterone injection

was ineffective in reinducing sexual receptivity in rats that had
received, progesterone at 48 hours.

Thus, with these particular

dosages of hormones, a progesterone-induced refractory period was
observed in rats.

That this refractory period, was due to proges-

terone and not to copulatory stimuli (Hardy & Debold, 1970) was
demonstrated by omitting testing in one group after the first

progesterone injection.

The next day's progesterone injection then

failed to facilitate sexual behavior.

If EB injection was added at

the time of the first progesterone injection, no refractory period

11

was evident.

This suggests that progesterone may
induce a refractory

period under appropriate circumstances and
that this inhibition

i^;

in part dependent on low levels of estrogen;
increasing titres of
estrogen

apparently overcome this inhibition

Lisk (1969a, 1969b) used another approach
to obtain a proges-

terone-induced refractory period.

Cannulae filled with estradiol

were implanted into the anterior-hypothalamus-preoptic
area of

ovariect oral zed female rats.

After 72 hours, progesterone was im-

planted subcutaneously and rats tested frequently over a
period of
72 hours for receptivity.

Progesterone first facilitated sexual

behavior, but by 72 hours the facilitation was absent.

If the sub-

cutaneous progesterone implant was then removed but reimplanted four
days later, the progesterone once again facilitated the induction
of sexual behavior.

This experiment, however, was confounded by the

fact that the same animals were tested several times over the testing
period.

Lisk, unfortunately, did not take into account the possi-

bility that prior copulatory stimuli may have contributed to his

results (Hardy & Debold, 1972).
In an investigation of the refractory period as it relates to
the estrous cycle. Powers

(1970) attempted to determine if progest-

srone acts to inhibit receptivity during the estrous cycle.

When

rats were ovariectomized either before or during the progesterone
surge, a progesterone injection 12 to 18 hours after an initial

testing for receptivity on the

night of proestrus was ineffective

in Inducing a second episode of receptivity.

injected at the time of

Since one pg of EB

or prior to ovciriectomy overcame this in-

hibition, the data suggest that during the estrous cycle the

12

refractoriness may be due to the lack of estr-dlol rather than to
the presence of progesterone.

It should, however, be emphasized

that there is no time during the estrous cycle when ovariectomy can
be performed so that the progesterone surge is blocked (to demonstrate

that progesterone is necessary for the refractoriness), yet estradiol

secretion remains normal (to demonstrate that diminished estradiol
levels are not responsible for the refractoriness).

In fact,

Powers' (1970) early ovariectomies occurred during the estradiol

surge (Butcher, Collins & Fugo, 197^) so that both estradiol

and.

progesterone levels may have been diminished.
Barfield and Lisk (197^) combined timed ovariectomies with

exogenous hormones.

The results of their work suggest that the

endogenous progesterone surge induces a refractory period to in-

duction of receptivity by estradiol + progesterone.

This, of course,

contradicts Powers' (1970) interpretation in that a prior proges-

terone surge inhibited the induction of receptivity in rats when
estradiol levels were othervrise high enough to induce heat.

Using a similar procedure. Powers and Moreines (1976) found
however, the presence or absence of a sustained elevation in

progesterone levels was without effect on estradiol + progesterone

induction of sexual behavior during the estrous cycle.

As the authors

point out, the procedure was one of concurrent inhibition, not
sequential inhibition.

During the naturally occurring estrous cycle

inhibition should, be of the sequential type, simply because the peak
in plasma progesterone concentration

estradiol concentration.

occurs after the peak in

In addition, it should not be surprising

the induction
if the endogenous progesterone surge does not inhibit
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of sexual behavior by the dose of
estradiol that they used (26.?

^/

kg body weight).

Using a sequential Inhibition procedure
rather than a concurrent
inhibition procedure, Powers and Morelnes
(1976) obtained what appears
to be a progesterone-induced refractory period
to subsequent stimu-

lation by progesterone.

With this procedure in which the rats'

endogenous estradiol was used to condition sexual behavior,
its
own progesterone used for inhibition and an exogenous
progesterone

injection used for subsequent facilitation, Powers and Moreines
(1976) report

some Inhibition by the endogenous progesterone.

In order to predict how progesterone might act on the brain
to exert its effects on behavior that have been outlined, a prior

understanding of progesterone 's mechanism of action in more
thoroughly-studied tissues is helpful.

The model of the Initial

interaction of a steroid hormone with reproductive tissues has been
described, and recently reviewed by several authors (G or ski & Cannon,

1976; Jensen & DeSombre, 1973; O'Malley & Means, 197^^ Yamamoto &

Alberts, 1976).

Basically, this model postulates that a steroid

hormone enters a cell, binds to a cytoplasmic receptor

permitting

translocation of the steroid-receptor complex to the cell nucleus
where It initiates an alteration In gene expression.

Although

initially proposed, for estrogen's Interaction with uterine cells

(G or ski,

Toft, Shyamala, Smith & Notides, I968; Jensen, Suzuki, Kawashima,

Stumpf, Jungblut & DeSombre, I968), the "two-step" model

has

2

Although admittedly an over siraplifl cat ion, for convenience this
model will be referred to as the "two-step" model (Jensen et al.
1968) to emphasize its dependence on cytoplasmic and nucleaar binding.

since been extended, in entirety or in
part to the interaction of all
steroid hormones with their respective
target tissues (Gorski &
Gannon, I976';

Jensen & DeSombre, 1973; O'Malley & Means.
197k)

including the central nervous system (McEwen
& Pfaff

,

I973. McEwen,

Denef, Gerlach & Plapinger, 197^? McEwen,
1975; McBwen, I976).

The utility of such a model for progesterone 's
mechanism of action
is indisputable.

It has led to tremendous advances in delineating

progesterone 's mechanism of action in the chick oviduct, and
recently
to advances in owe understanding of its action in the mammalian

uterus

The model target tissue for progesterone' s mechanism of action
in modulating gene expression is the chick oviduct because of its
well-documented response of synthesis of the egg-white proteins,

avidin and ovalbumin under discrete hormonal conditions (Schimke,
McKnight, Shapiro, Sullivan & Palacios, 1975; O'Malley, McGuire,

Kohler & Korenmeum, I969).

Progesterone in either estrogen-

stimulated, or estrogen- withdrawn chicks induces the synthesis of

avidin (O'Malley et al.

,

I969; Korenmann & O'Malley, I968; Means &

O'Malley, 1971); ovalbumin synthesis is induced by either estrogens
or estrogens and progesterone (O'Malley et al., I969; Palmiter,
1972).

The intermediary mechanism of progesterone 's action on

avidin synthesis is believed to be as follows.

High affinity

progestin-specific binding proteins are present in the cytoplasm of
oviduct cells (Sherman, Corvol & O'Malley, 1970; O'Malley, Sherman

& Toft, 1970).

Administration of progesterone results in binding

to these cytoplasmic receptors (O'Malley, Toft & Sherman, 1971)
and subsequent trsuislocation to the nuclear compartment (O'Malley
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et al.. 1971) where the
hormone-receptor complex binds
to chromatin
acceptor sites (Spelsberg.
Steggles & O'Malley. I971).
One subun.t
of the hormone-receptor
protein is believed to bind
with high affinit
to a limited number of sites
on DNA (O'Malley & Schrader,
I972). and
one subunlt to nonhistone proteins
(Spelsberg. Steggles. ChytlA

O'Malley, 1972; Schrader, Toft
& O'Malley, 1972).

At this site it

may increase the number of RNA
chain initiation sites available
to
RNA polymerase (Schwartz, Kuhn,

Buller. Schrader & O'Malley, I976).

thus stimulating synthesis of
specific species of mRNA (O'Malley &

HcGuire, I969).

The transcriptional products are
transported to the

cytoplasm where the endpoint of translation
into avidin may take

place (O'Malley & Means, 1974).

In the estrogen-stimulated chick

oviduct, this specific response may occur
despite the fact that

progesterone may also cause a transient decrease
in total protein
synthesis (Means & O'Malley, 1971 ).
In mammals, the model system for progesterone
's mechanism of

action is of course, that organ in which progesterone
exerts some of
its most obvious morphological effects, the uterus.
uterus, progesterone both synerglzes with

and.

In the rodent

antagonizes estrogens'

stimulation of various biochemical and physiological events.

Pro-

gesterone administered by itself has little (Bronson & Hamilton,
1972? Harris, Lerner & Hilf, I968) or no (Harris et al., I968

;

Wade

& Feder, 1974) effect on most uterine responses, althugh the fact
that it can, by itself, induce deciduoma formation (Madjerek, 1972;

Madjerek & Smit-vis, 1974; O'Malley & Strott, 1973) and corrugation
of the luminal epithelium (Martin, Finn & Carter, 1970) cannot be
overlooked.

Progesterone facilitates estrogens' effects on responses

.16
such as increases in uterine weight (Bronson

i

Hamilton, I972), RNA

Synthesis (Bronson 4 Hamilton, 1972, Miller,
1975). protein synthesis
(Bronson & Hamilton, 1972; Wade & Feder,
197^), RNAiDNA ratios (Bron-

son & Hamilton, 1972), stromal mitosis (Clark, I97I;
Clark, 1974)
and endometrial proliferation (Zarrow, Yochim & McCarthy,
1964).

Progesterone can induce decidualization (Yochim & DeFeo, I962)
and
stimulate the change of the endometrium from a proliferative phase
to a secretory one (Finn & Porter, 1975; McPhail, 1934).

Within prescribed dosage and temporal parameters, progesterone

also antagonizes most of estrogens' effects including many of the
same responses

which it facilitates.

Progesterone inhibits

estrogen-induced increases in uterine wet weight (Harris et al., I968;
Hsueh, Peck & Clark

,

1975; Bo, Poteat, Krueger & McAlister, I97I;

Martin & Finn, 1970 ), RNA synthesis (Bronson & Hamilton, 1972),
protein synthesis (Bronson & Hamilton, 1972), DNA synthesis (Bronson

& Hamilton, 1972; Krueger, Bo & Garrison, 1974), RNAtDNA ratios
(Harris et al., I968), luminal and glandular epithelium mitosis
(Clark, 1971» 197^; Martin & Finn, 1970), cAMP levels (Rinard &

Chew, 1975)

»

phosphorylase a levels (Rinard & Chew, 1975) » glucose-

6- phosphate dehydrogenase activity (Harris et al., I968), lipid

content (Harris et al., I968), retention of luminal fluid (Bo et al.
1971 t Kennedy & Armstrong, 1975; Cleraetson Verraa & DeCarlo, 1977;

Armstrong, I968), glycogen concentrations (Zarrow et al.
et al., 1971)
block!

»

,

1964; Bo

and of course myoraetrial contractions (progesterone

O'Malley & Strott, 1973; Davies & Ryan, 1972; but possibly

not in the guinea pig. Porter, 1970).

Whether progesterone facilitates or antagonizes estrogens'

action on a par.ticular response seems to be
critically dependent on

both tne injection regimen and dosage parameters
for both hormones.
In rats and mice, combined treatment with estrogen +
progesterone

far one (Bo et al., 1971), three (Hsueh et al.,
1975), four (harris
et al, 1968) or seven (Muggins & Jensen,
1955) days antagonizes

uterine growth.

Conversely, Bronson & Hamilton (1972) demonstrated

the progesterone synergizes with estradiol to increase uterine wet

weight in some ciroumstajices.
Days 1-3 and

7,

When estradiol was administered on

the addition of progesterone on Days 4-7 resulted

in more growth than when progesterone was omitted.

Early attempts to demonstrate specific progestin binding in
the rodent uterus failed.

With autoradiographic techniques,

progesterone was not found to concentrate in any subcellular fraction
(Rogers, Thomas & Yates, I966; Taylor & Wright, 1971).

Likewise,

other early attempts to measure in vivo uptake of radioactively

labeled progesterone into uterine tissue revealed little or no

concentration relative to nontcirget tissues (Riegel, Hartop &
Kittinger, 1950; Berliner & Wiest, I956; Wiest, I963; Lawson &

Pearlman, 1964; Laumas & Farooq, I966)
(1970) reported

uterus,

and. in

^ vivo

.

In 1970, Falk and. Bardin

uptake of -^H-progesterone in the guinea pig

that year Milgrom and Baulieu (1970) reported proges-

terone binding by the cytosol of rats* uterus.

The major obstacle to characterizing progesterone binding has
been the rapid dissociation of progesterone from its cytoplasmic
binder (Feil, Glasser, Toft & O'Malley, 1972).

Several procedural

adaptations have been used recently which circumvent this inherent
technical problem by decreasing the rate of dissociation.

Thio-
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glycerol is

of

en used in buffers because it stabilizes
some forms

of the chick oviduct progesteone receptor (Schrader,
Smith k Coty, 1976).

1975; Schrader,

Addition of glycerol to buffers markedly

slows dovm the dissociation rate of progesterone
from its mammalian

uterine receptor (Fell et al., 1972).

With a charcoal adsorption as-

say, Fell, Glasser, Toft & O'Malley (1972) have shown
that glycerol

may actually increase the half-life of the hormone-receptor
complex
by as much as 10-15 times.
gestin,

17*<,

Lastly, a highly potent synthetic pro-

21-dimethyl-19-nor pregna-4,9-diene-3,20-dione, has

been used to dissociate progestin-specific binding from lessspecific binding (Philibert & Raynaud, 1973; Philibert & Raynaud,
1974).

Part of the early ambiguity in the understanding of progesterone
binding in mammalian uterus may have been due to the fact that the

high affinity binding component is dependent on estrogen priming
(Chen & Leavitt, 1975).

Estrogen pretreatment seems to be a pre-

requisite for high levels of progesterone binding, a fact consistent
with progesterone 's dependence on estrogen priming for most physiological responses.

Estrogen injections dramatically increase the

amount of in vivo binding in the uterus but not nontarget tissues
of rodents (Corvol, Falk, Freifeld & Bardin, 1972; Falk & Bardin,
1970; Leavitt & Blaha, 1972).

This increase is also seen with in

vitro assay of progesterone binding (Chen & Leavitt, 1975; Leavitt
et al,,1974; Milgrom, Atger & Baulieu, 1970; Freifeld, Feil & Bardin,

1974; Luu Thi, Baulieu & Milgrom, 1975; Faber, Sandraann & Stavely,

1972a, b).

In an

iji

vitro assay using hamster uterine strips incu-

bated, with estradiol, the increatse in progesterone binding was

found to be protein-synthesis-dependent since it is inhibited by
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cyclohexlmidfi ^Faber, Saffran, Chen & Leavitt,
I976), and RNA-

synthesis-dependent since it is inbhibited when
actinomycin-D is

present prior to, but not after, the sixth hour
of a 12 hour incubation (Faber et al., I976.
A central requirement of the two-step model
for progesterone'

action is that the hormone bound to its receptor is
translocated to
the cell nucleus.

Using autoradiography, concentration of radio-

activity has recently been found over cell nuclei of the uterus
after injection of ^H-progesterone (Warmebourg, 1974; Stumpf & Sar,
1973).

With liquid scintillation techniques tritium

has been re-

covered, from cell nuclei of the uterus after -^H-progesterone injection

(Atger, Baulieu & Milgrom, 197^; Fell, Miljkovic & Bardin, 1976).

A progestin-specific receptor has been reported in the nuclei of

*at uterine tissue by an exchange assay (Walters & Clark,
Hsueh, Peck & Clark, 197^).

I976;

Following a progesterone injection, cyt-

oplasmic progesterone receptors are depleted

tors accumulate in the nuclear fraction.

and.

progesterone recep-

This presumably represents

translocation of the receptor from the cytoplasm to the nucleus (Saffrsin,
Loeser, Bohnett & Faber, I976

197^)

•

;

Walters & Clark, 1975; Hseuh et al.,

These reports .are consistent with the notion that binding

which appeairs in the nucleus is actually due to transformed
translocated, cytoplasmic receptors (Fell

experiments of in vivo binding of

3

Sc

Bardin, 1975).

and.

In

H- progesterone, however, only slightly

more radioactivity accumulates in the nuclear fraction than in the
cytosol (Atger et

aO...

197^1 Fell et aJ., 1976).

Although this is not

strong evidence for a nuclear site of action far progesterone, the
date are

_not

inconsistent with the "two-step" model of steroid action
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(Gorski & Gannon, I976; Jensen & DeSombre, I973;
O'Malley & Means,
1974).

There have been numerous reports of failure to extend
the "twostep" model of progesterone action to the pituitary
gland

central nervous system.

the

and.

Many reports have demonstrated that in vivo

uptake into whole homogenates of these tissues is nonsaturable
(Wade & Feder, 1972a; Luttge, Wallis & Hall,

I97/+;

Iramain & Strott,

1973; Whalen & Gorzalka, 197^) and. seems to be nonspecific.

Its

only selectivity seems to obey a rule similar to the "polarity rule"
by which steroids bind to plasma proteins (Westphal, 1973).

polar steroids are taken up in greater concentrations

and.

Less

retained

more than steroids with greater polarity (Wade & Feder, 1972b).
In this nonsaturable system, uptake in midbrain is greater than
in hypothalamus which is greater than cortex (Wade & Feder 1972a;

Luttge et al., 197^; Wade & Feder, 1972b; Seiki, Miyamato, Yameshita

& Kitani, I969; Luttge, Chronister, & Hall, 1973; Wade, Harding & Feder,
1973; Whalen & Luttge, 1971a, b).

in the pituitary gland.

(

Highest uptake is sometimes observed

Whalen & Gorzalka, 197^; Luttge et al., 1973;

Whalen & Luttge, 1971; Presl, Figarova, Herzmann & Rohling, 1975).

There are minor differences between experimenters in the ordering of
other tissues, most of which may reflect variations in dissection

procedures

Reports of indirect evidence for satmrability of this whole
homogenate uptake system exist.

Whalen' s group (Whalen & Gorzalka,

1974; Whalen & Luttge, 1971a, b) reports that adrenalectomy increases

the absolute concentration of radioactivity in most regions.

How-

ever, others have pointed out that when tissue/plasma ratios are
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computed, which taJce into account the higher
levels of radioactivity
in the blood, plasma of adrenalectomi.-sed.
animals, this difference is

eliminated(Wade & Feder, 1972a, Zigmond,
1975).

Subsequent experi-

ments in mice have failed to replicate the
initial effects of

adrenalectomy (Luttge et al.

,

I973).

In vitro cytoplasmic receptor assays have had
mixed results.

Sucrose density gradient centrifugation experiments
have failed to
detect progestin binding in the hypothalamus or pituitary
of rats
(Davies, Naftolin & Ryan, 197^; Davies, Siu, Naftolin &
Ryan, 1975;
Kato, 1975), guinea pigs (Atger

et^.,

1974; Iramain, Danzo, Strott

& Toft, 1973) and hamsters (Reel & Shih, I975).

Using gel filtration

both Seiki and Hattori (1973) in rats, and Iramain, Danzo, Strott and

Toft (1973) in guinea pigs have observed binders for progesterone in
the hypothalamic area

and.

pituitary; other experLmenters have failed

to confirm these findings (Atger et al., 197^).

Luttge and Wallis

(1973) demonstrated, saturable binding in whole tissue of the inter-

peduncular region and pituitary, but no attempt was made to demon-

strate steroid, specificity.

With the exception of one series of experiments, attempts to
observe cell nuclear localization of radioactively labelled proges-

terone after in vivo injection have all failed (Atger

^ al.,

1974;

Msirrone & Feder, 1977; McEwen, deKloet & Wallach, 1976). Although

Karavolas reported concentration of
and.

3

H- progestins in crude hypothalamic

pituitary cell nuclei (Karavolas & Herf, 1971; Cheng & Karavolas,

1973; Robinson & Karavolas, 1973)

1

this binding:

l) is not diminished

by boiling, which indicates that it is not pr otein- bound

,

not found, in purified, nuclei (Cheng & Karavolas, 1975a, b).

and 2) is
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In the
of

on-j

study which isolated cytosol after in vivo
injection

H-progesterone, high initial concentration and
retention were

found in the median eminence and pituitary which
is difficult to
reconcile with the hypothesized, nuclear site of action.

They used a

very crude cytosol fraction (800 x £ for 10 minutes),
so their

results may be attributable to contamination (Seiki &
Hattori, I973).

With autoradiography, Sar & Stumpf (1973) found, nuclear concentration of tritium after an injection of "^H-progesterone in a
circumscribed, area which included, the arcuate nucleus, preoptic

periventricular nucleus
an injection of

and.

preoptic suprachiasmatic nucleus after

H-progesterone.

They also observed enhancement of

accumulation by estradiol priming and competition by unlabeled,
progesterone.

Warembourg, however, failed, to replicate these findings.

The latter steps in progesterone 's central mechanism have been
studied, less extensively and. lend support to an action on protein

synthesis

and.

perhaps on transcription.

Protein synthesis in rats'

neural tissues varies cyclically over the estrous cycle (Litteria,
1973; Moguilevsky, Sacchi, Christot, 1971).

This effect is likely due

in part to estradiol's effects on translation (Wade & Feder, 1974).

Progesterone injection increases overall protein synthesis in all
areas of the brain that have been studied as well as in the uterus;
it has no effect in non-target tissues such as the diaphrcigm (Wade

& Feder, 1974).

In addition, hypothalamic implants of the protein

synthesis inhibitor

,

cycloheximide have been shown to prevent

progesterone 's inhibition of sexual behavior in guinea pigs (Wallen,
Goldfoot, Joslyn & Paris, 1972).

Progesterone 's positive feedback

on LH release is inhibited by systemic injections (Jackson, 1972) or
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hypothalamic Implants (Jackson.
1975) of the RNA synthesis Inhibitor,
actinomycin-D.

The purposes of this dissertation are
three-fold.
I, progesterone 's inhibitory
effect

rats Is partially characterized..

In Section

on female sexual behavior in

Section II tests the hypothesis

that progesterone' antiestrogenic
effects are mediated by a mechanism
s
such as that proposed, for the synthetic
estrogen antagonists.

In

Section III, the synthetic progestin. R
502O is used to investigate
the possibility that progesterone 's effects
on sexual behavior are
mediated, by a "two-step" mechanism in the
brain.

GENERAL PROCEDURE
Behavioral testing .

Female Sprague-Dawley rats were
purchased

from a commercial supplier (Charles
River Breeding Laboratories. Wil
mington, Massachusetts).

They arrived in the laboratory weighing

125-150 g and weighed 250-350 g at the time of
testing.

All animals

were housed in group cages with pine wood
shavings as bedding.

Environmental illumination was provided from 2^00-1200
hours daily
and room temperature was maintained at
21-23°C.

Purina Laboratory

Chow and tap water were available ad lib.
All animals were ovariectomized under methoxyf
lurane (Metofane)
anesthesia through a single midventral incision.

After ovariectomy

rats were housed singly in Wahmann LG-75SA wire-mesh cages.

Two

weeks later, rats were given 2 yg of EB followed 42 hours later by

0.5

fig

of progesterone and were screened for the presence of lor-

dosis either by response to mounts by a male or by a manual stimulation technique (Zucker, 1967b).

Only females that showed lordosis

responses under these conditions were included in the experiments.
When an animal was used in two studies, approximately 2 weeks were
allowed to elapse between tests and subsequent injections.

All

steroids were injected in 0.1 ml of sesame oil except where other-

wise noted.

All tests for lordosis took place in a 76-cm (diameter) round
testing arena with walls that were 15 cm high.

Three sexually

experienced Sprague-Dawley male rats were adapted to the arena for

30 minutes prior to the introduction of the first female on a

given day.

All tests occurred

1 to 3

hours alteac the onset of the

dark period

under dim red illumination.

experimenter blind to treatment groups.

Testing was done with the
Tests consisted of ten

vigorous mounts with thrusting by the males.
lordosis was rated as

0,

1.

Quality of each

2 or 3 (no, slight, moderate and full

dorsiflexion, respectively) after Powers and Valenstein
(1972).

If an ejaculation occurred during a test, the female
was removed

from the arena for 10 minutes.
In vivo - H -estradiol uptake
2, 4,

6,

.

Rats received injections of

7- ^H-estradiol-17p (Specific Activity =91.3

Ci/mmole, New England Nuclear) dissolved in either oil or ethanol-

water

{ZQP^)

,

administered through various routes, to be described

in each experiment.

At a particular time after injection, rats

were anesthetized with sodium pentobarbital (Nembutal), a blood

sample taken in a heparinized syringe via cardiac puncture, and the

rats were perfused with 0.15 M cold saline.

The brains were dis-

sected as described in each experiment and the entire pituitary
gland, removed.

All steps were performed, at 4°C.

Tissues were

weighed, to the nearest 0.1 mg and homogenized in Teflon-glass co-

axial homogenizers.
and.

An aliquot of the whole homogenate was taken

a purified, nuclear pellet isolated by the method of Zigmond and

McEwen (1970) using the following solutions:
(N I)

—

l) Nuclear Isolation I

0.32 M sucrose, 1 mM potassium phosphate, 3

^

magnesium

chloride, 0.25% Triton X-100 (v/v), pH 6.5; 2) Nuclear Isolation II
(N 11)

—

.32 M sucrose,

1 mM

potassium phosphate, 3

chloride, pH 6.5; 3) Nuclear Isolation III (N III)

sucrose I 1 mM potassium phosphate, 3

^

—

^

magnesium

2.39 M

magnesium chloride, pH 6.5.

Tissues were homogenized with 20 slow up-aind-down strokes in 2 ml N

I,
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Two hundred ul of whole horaogenate was taken
fuged at 800 x g for 10 minutes.

and,

the remainder centri-

The supernatant was discarded,

the pellet resuspended in 2 ml N II; and. the mixture
centrifuged at

800 X g for 10 minutes.
resuspended. in

thoroughly.

OA

The supernatant was discarded, the pellet

ml N II,

and.

2.1 ml N III added and mixed

The mixture was centrifuged for 90 minutes at 20,000
x

g to obtain a nuclear pellet.

The supernatant was discarded, and the

purified nuclear pellet removed from the centrifuge tubes with
3 x 500
ul 0.01 M citric acid.

Radioactivity was extracted from the whole homogenate

and.

nuclear pellet fraction with 3 x 4 ml of toluene scintillation cocktail (5.0 g 2,5-diphenyloxazole and 0.05 g l»^bis-2(5-phenyloxazolyl)).

benzene/liter scintillation-grade toluene).

After extraction of

radioactivity the whole homogenate and nuclear pellet fractions
were washed, with 5

rol

of ethanol, and protein content was analyzed

by the method, of Lowry, Rosenbrough, Farr and Randall (I951).
Blood samples were centrifuged.

pipetted into scintillation vials.

and.

100

jul

aliquots of plasma

Twelve ml of scintillation cock-

tail were added and the mixture counted after vigorous shaking.

Tissue radioactivity levels were expressed, as disintegrations per
minute (DPM/mg protein) and corrected, for differential plasma

radioactivity levels by expression as tissue/plasma ratios

mg protein:

(DPM/

DPM/u1 plasma) for reasons that have previously been

delineated. (McEwen 4 Pfaff, 1970).

In vivo - -^ - progestin uptake

.

Techniques for investigating the

uptake and binding of -^-progestins are similar to those used for
estradiol with several exceptions.

All buffers contained 12 mM

\-
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W

ana

^„

„^

^^^^^
optical for .tudyln, the
progestin receptor fro.
^a^allan
uterus (Pell. Glasser.
Toft . O-Halley.
1972, PhillWt . Raynaud.
1973
197^., Toft 4 Sherman.
1975). Also, l^edlately
after dissection,
tissues Here placed into
homogenizers stored at 4°C.

have

28

SECTION

I,

INHIBITION OF SFJCUAL BEHAVIOR - THE RAT AS
A

HYPOSENSITIVE GUINEA PIG

In guinea pigs, unlike rats, inhibition is
usually observed

within broad ranges of doses of estrogens and
progesterone.

Following

a subcutaneous injection of radioactively labeled
progesterone,

guinea pig brains take up more progesterone relative
to blood
plasma levels and retain the progesterone for a longer
duration than
do rat brains (Wade, Harding & Feder, 1973).

If the ambiguity of

progesterone 's antagonistic effects in rats is related, to the
lesser

neural uptake and/or retention of progesterone, then the progesterone

dose necessary to inhibit lordosis should, be greater in rats than in
guinea pigs.

Perhaps sufficient quantities of progesterone must be

administered to maintain neural progesterone concentrations at

some critical level.

In addition, previous work (e.g.. Powers &

Zucker, I969) suggests that there may be a critical relationship

between the level of estradiol

sind

the level of progesterone administered.

The factors which may influence sequential inhibition have also
not been described for rats.

However, with very low doses of estro-

gen priming (Nadler, 1970) or with intrahypothalamic estradiol
implants (Lisk, 1969)1 progesterone may sequentially inhibit in
ovariectomized. rats.

During the estrous cycle, progesterone has been shown to exert
at leaist a minor sequential inhibitory influence on the facilitation

of a subsequent episode of sexual receptivity by progesterone
(powers

ic

Moreines, 1976).

Other reports of both success and failure

(Barf i eld 4 Lisk, 197^; Powers, 1970; Powers & Moreines, 1976) in
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finding inhibition by progesterone
in estrous-cycling rats have
used, a concurrent inhibition
procedure.

In light of the conflictiiig

evidence for sequential inhibition in
ovariectomized. rats (Zucker,
1967a) and in estrous-cycling rats, it
is necessary to first

document sequential inhibition by
progesterone in OVX rats and then
to characterize the conditions under which
it occurs.

Only after

we have characterized, progesterone 's involvement
in a behavior
can we make predictions of its mechanism
of action.

In Section I

progesterone 's involvement in both concurrent and
sequential inhi-

bition in OVX rats will be characterized.
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EXPERIMENT

DAILY INJECTIONS OF PROGESTERa.E AND ESTRADIOL BENZOATS

1»

Charonic daily injections of large doses of progesterone
with

EB result in lower levels of sexual receptivity than small doses
of progesterone with EB when tested after 10 days of treatment

(Edwards et al., I968).

However in the previous work, only the

effects of chronic injections of the two hormones were investigated.

The first experiment is an attempt to

replicate these findings and

extend them to a lower dose of EB and a more typical testing pro-

cedure in which testing occurs 5-7 hours after a progesterone
injection.

Procedure

.

Twenty-two ovariectomized. rats were divided into

three groups receiving subcutaneous injections daily of either 2 wg
of EB at 0600 hours (n=0), 2

yiig

of EB + 0.5 mg progesterone (n=7) or

2 jug of EB + 5 mg of progesterone (n=6).

injected with 0.5

nig

On Day 10 all rats were

of progesterone (O8OO hour^ and tested 5-7

hours later for sexual receptivity.

Results .

Although high levels of progesterone inhibited the

induction of sexual behavior when compared with the group which
received EB alone, U (6,9) =
group, U (6,7) = 0,

J2

0,

2<

.005*

or the low progesterone

< 'OOSf low doses of progesterone did not

significantly inhibit sexual behavior, U (7,9) = 17.5. 2 < 'lO*
(Figure 1).
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Figure

Mean lordosis ratings (- standard error) of ovari-

1.

ectomized rats given daily injections of 2 ug of estradiol benzoate
(EB) alone, 2

Aig

of EB + 0.5 mg of progesterone, or 2

of progesterone for nine days.

/Ug

of EB + 5 mg

(Tests occurred on the tenth day

and were preceded by a single injection of 0.5 mg of progesterone.)
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^HI^IMENT

CONCl^RENT INHIBITION INFLUENCE OF PROGEST^ONE
DOSE

2:

The results of Experiment
1 demonstrated that with
chronic
daily injections of
progesterone and EB. progesterone
in a sufficiently
high dose can antagonize the
actions of estradiol in the
induction
Of sexual receptivity. In
Experiment 2 the effects of
various doses
of progesterone administered
simultaneously with EB were studied
in
a typical induction procedure
a single injection of EB
followed

-

42 hours later by a single injection of
progesterone.

Procedure.

Thir :y-three ovariectomized rats
were divided into

five groups receiving various doses
of progesterone or oil.

All

rats were injected subcutaneously with
2 ms of EB at 1400 hours.

At this time either oil (n=8).
0.5 mg (n=7),

1

mg (n=6). 2.5 mg

(n=6), or 5 mg (n=6) of progesterone
was injected at a separate

subcutaneous site.

Forty-two hours later (0800 hours),
0.5 mg of

progesterone was administered, and sexual
receptivity was tested
5-7 hours later.
Results.

Dosages of 2.5 mg of progesterone and
5 mg of proges-

terone significantly inhibited the induction of sexual
receptivity
when compared with rats that received EB + oil,U
(6,8) =
U (6,8) = 1,

2 <

.005 (Figure 2).

3,

^ <

.005;

Neither the 0.5 mg progesterone

nor the 1 mg progesterone group was significantly different
from the

controls which received EB

auid

oil.
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Figure 2.

Mean lordosis ratings (+ standard error) of

ovariectomized rats treated with various doses of progesterone or

sesame oil simultaneously with 2

^ig

of estradiol benzoate.

(All

groups received 0.5 mg of progesterone at 42 hours and were tested
at approximately 48 hours.)
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EXPERIMENT

Jt

CONCURRENT INHIBITION

- TEJIPOP^L

DEPENDENCE OF

THE PROGESTERONE INJECTION

Experiment 2 showed that lordosis can be readily
inhibited in

a typical induction procedure if a sufficient dose of
progesterone
is administered simultaneously with the EB injection.

The purpose

of Experiment 3 was to broaden the basis for comparison of
the antag-

onistic effects of progesterone on sexual behavior in guinea pigs
and rats.

Progesterone was administered at various intervals prior

to the injection of EB in a typical induction procedure to demon-

strate that progesterone

caji

inhibit estradiol's action when present

temporally close to the EB injection but not if separated by a

longer duration.
and 5

rog

Doses of the two hormones were chosen (2 yg of EB

of progesterone) that are approximately behaviorally

equivalent to the levels used in a similar experiment with guinea

pigs (Wallen et al., 1975).

Procedure .

Fifty-four ovariectomized rats were distributed

into groups receiving 5
to the EB injection.

nig

of progesterone at various times prior

Progesterone was injected subcutaneously either

2 hours (n=9), ^ hours (n=ll), 16 hours (n=8) or 48 hours (n=6) prior

to the injection of 2 wg of EB.

The control group (No P; n=15)

received, oil simultaneously with the EB injection.

At 42 hours, 0.5

mg of progesterone was injected and emimals were tested 5-7 hours
lateo:.

Data for the 0 hour group that received 5

nig

of progesterone

simultaneously with the EB injection were tciken from Experiment 2.

Results

.

When compared with the No P controls, progesterone

injected either simultaneously with EB, U (6,15) ° 4,

<

'005.

2 hours prior to EB, U (9.I5) = 19.

£ <

.02,

k hours prior to EB,

U (11.15) = ^.5, 2 < .002, or 16 hours
prior to EB, U (8,15) =
10.5.

2 <

.002, inhibited the action of estradiol in
the induction

of sexual receptivity (Figure 3).

However, if progesterone was

given 46 hours prior to EB, there was no evidence
of inhibition of
lordosis.
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Figure 3.

Mean lordosis ratings (+ standard error) of

ovariectoraized rats treated with 5

of progesterone either

simultaneously with or at various intervals prior to 2
estradiol benzoate.

>ig

of

The No P control group received only an

injection of oil simultaneously with the estradiol benzoate
injection.

(All groups were injected with 0,5 mg of progesterone

at k2 hours

and.

tested at approximately 48 hours.)
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EXPERIMENT 4i

CONCURRENT INHIBITION

- INFLUirNCE OF

ESTRADIOL

BENZOATE DOSE

The results of Experiment 3 are remarkably
similar to those
obtained in guinea pigs with a quite different
ratio of the two

hormones (Wallen et al., 1975).

It is now quite clear that the

basis for the original failure to observe antagonism
by progesterone
of sexual receptivity in ovariectomized rats was due
to an insuf-

ficient dose of progesterone (Zucker, 1967a; 0.16 or 1 mg of
progesterone).

pregnancy 6

Since during some stages of pregnarxcy and pseudo-

Aig

of EB can overcome the antagonism seen with 2

;ug

of

EB (Powers & Zucker, I969), it also seems that the dose of estradiol
is critical.

Experiment k tested this hypothesis by varying the

dose of EB while holding the progesterone dose constant.
Procedure .
either 6

/jg

Twelve ovariectomized rats were injected with

of EB (n=6) or 10 Mg of EB (n=6) simultaneously with 5

mg of progesterone.

mg of progesterone
hours.

Forty- two hours later, all animals received O.5
and.

were tested for sexual receptivity after 5-7

Data from a group from Experiment 2 that received 2 ug of

EB + 5 mg of progesterone (n=6) were included for comparison.

Results and discussion .
different

ftora

the 2

>ug

The 10

jug

EB group was significantly

EB group, U (6,6) = 4, 2 < •05t but the 6

EB group was not, U (6,6) = 10,

2 >

jog

.20 (Figure 4).

The results of this experiment demonstrate one more reason for
the lack of positive findings on progesterone antagonism of sexual

receptivity in rats.

Increasing the dose of EB can clearly overcome

the inhibition by a particular dose of progesterone (in this case, 5

mg).

Some previous research has used 6 Mg EB for the induct!

sexual receptivity (Zucker, 1967a).

k2

Figure

Mean lordosis ratings (+ standard error) of

ovariectomized. rats injected with 5

various doses of estradiol benzoate.

nig

of progesterone (P) +

(Forty-two hours later all

groups received 0,5 mg of progesterone followed approximately 6
hours later by testing.)
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EXPERIMENT

CONCURRENT INHIBITION - INFLUENCE OF REPEATED

5:

PROGESTHiONE INJECTIONS

Following a subcutaneous injectk>nof 40 ^Ci of
^H-progesterone
(approximately 6.3 p^), the brains of guinea pigs take
up more

progesterone and retain it for a longer period than do rat
brains.

Significant levels of progesterone are retained in neural
tissues
of guinea pigs in excess of 24 hours after an injection of
approxi-

mately 0.3

in rats, progesterone is undetectable by 16 hours.

As

already demonstrated., the dose of progesterona requii-ed for concurrent inhibition of sexual receptivity in rats is well in excess
of that required, in guinea pigs (approximately 2.5

rag

of progesterone

for 2 «g of EB for rats vs. approximately 0.4 mg of progesterone for
6

jLig

of EE in guinea pigs;

(Wallen et al., 1975; Zucker, I966).

If the basis for less sensitivity in rats is related to the lack of
maintenance of significant quantities of progesterone in neural
tissues, then the same quantity of progesterone distributed into

multiple injections should, be more effective than a single injection

in inhibiting lordosis.
Procedure .

Experiment 5 tests that hypothesis.

Eleven ovariectomized rats were divided into two

groups receiving two progesterone treatments in counterbalanced
order.

One group first received 1 mg of progesterone at the time of
jjg)

injection followed by four oil injections at 4, 8, 12,

and 16 hours.

The other group first received 0.2 mg of progesterone

the EB (2

at each of these five injection times for a total of 1 mg of progester
one.

At 42 hours, all rats received. 0.5 mg of progesterone followed

5-7 hours later by testing.

Eight days later, treatments were

reversed so that each ajiimal served as its own control in a withini

45
subjects desig;..

Results and discussion.

Treatment vdth five injections of 0.2

ng of progesterone resulted in significantly
lower levels of lordosis
than a single injection of

1

mg progesterone, T (ll) = 4,
^ < .10.

Wilcoxon, (Figure 5).

These results support the hypothesis that the
basis of rats'

hyposensitivity to progesterone is related to their lack
of retention
of progesterone in neural tissues.

The findings are consistent with

the notion that a function of the large single doses of
progesterone
required, to antagonize the induction of sexual behavior
in rats might

be to maintain neural progesterone concentrations at some
particular
level.
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Figure -5.

Meaii

lordosis ratings (+ standard error) of ovari-

ectoniized rats injected with 1 mg of progesterone either in one

injection simultaneously with 2

injections of 0.2

rag

Aog

of estradiol benzoate or in five

each at 4-hour intervals starting at the same

time as the initial 2 yg of estradiol benzoate.

(Forty-two hours

after the estradiol benzoate injection all rats received 0.5 mg of

progesterone followed approximately 6 hours later by testing.)
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EXPERIMEMT

SEQUENTIAL INHIBITION - INFLUENCE
OF PROGESTERONE

6,

DOGE

It now seems likely that
progesterone has some inhibitory

influence on sexual receptivity in
estrous-cycling rats (Powers &
Moreines. 1976) as it does in guinea
pigs (Goy, Phoenix & Young,
1966).

As discussed, in OVX rats, there
are reports of both success

(Lisk, 1969; Nadler, 1970) and failure
(Zucker, 1967a) to obtain

sequential inhibition of sexual receptivity
by progesterone.

Experiments 1-k suggest that concurrent inhibition
by progesterone
is critically dependent on the doses of both
progesterone and EB.

concurrent inhibition

and.

If

sequential inhibition are caused by a

common neurochemical event, one would expect similar
dose-response

relationships for the latter which would explain the
previous conflicting observations.

That is, sequential inhibition might also

require high levels of progesterone with low levels of estradiol.
Experiment 6 I obtain a dose-response relationship for sequential
inhibition by progesterone using a low priming dose of EB.

Tests

occurred. 1 and 2 days after EB injections to ensure, that the neural

substrate would, remain "conditioned" by estradiol for the second
test.

The first test (30 hours) is a test of the facilitatory

influence of the particular dose of progesterone

and.

the second (54

hours) is a test for a subsequent inhibitory influence (sequential

inhibition).

Procedure .
five groups.

Twenty-nine ovariectomized rats were divided into

All rats received 2

they received either oil

(n«=6),

/Jg

of EB at 0 hours.

At 24 hours

0.1 mg (n=6), 0.5 mg (n=5), 1 mg

In

k9
(n=7) or 2.5 mg of progesterone (n=5).

Five to 7 hours after

progesterone injections (30 hours), rats
were tested for sexual
receptivity.

At 48 hours, all animals were given
0.5 mg of progester-

one and tested 5-? hours later
(54 hours).

Results

and.

discussion.

Either O.5 mg. 1 mg or 2.5 mg of

progesterone facilitated lordosis at
30 hours, but 0.1 mg of
progesterone

did.

not (Figure 6).

One mg of progesterone, U (6,?) = 4.
£ < .05, and 2.5 mg of
progesterone, U

(/f,6) = 2.

2 <

.05, indiiced a refractoriness to the

second, progesterone injection, whereas oil,
0.1 mg or 0.5 mg of

progesterone did

not,

(Figure 6).

A lordosis rating could not be

obtained, for the second test of one rat in the
2.5 mg group because

it would, not allow the males to mount.

The results of this experiment indicated that under conditions
of relatively high levels of progesterone, sequential inhibition can

be observed, in rats.

It should, be emphasized that although 0.5 mg of

progesterone facilitates sexual behavior at 30 hours, it does not
subsequently inhibit receptivity measured at 54 hours.

facilitatory

and. ajitagonistic

Thus, the

influences of progesterone on

sexual receptivity are dissociable in rats.

Unlike the situation in

guinea pigs (Morin & Feder, 1974) a higher dose of progesterone is
required to inhibit sequentially than to facilitate.
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Figure

6.

Mean lordosis ratings (+ standard error)
of ovari-

ectomized rats injected with oil or various
doses of progesterone

24 hours after 2

^

of estradiol benzoate.

Rats were tested 5-?

hours later (30 hour test), administered
0.5 mg of progesterone at

^

hours, and tested again 5-7 hours later
(54 hour test).
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EXPEBIMENT 7.

SBSUfflTIAL INHIBITION - ABE
COPUUTQRY STIMULI

NECESSARY?

The results of Experiment 6
clearly point out that copulatory
stimuli alone are not sufficient
to induce the refractoriness
to
subsequent progesterone because all
of the groups that received low
doses of progesterone also received
copulatory stimuli on the first
test, but were not inhibited as
measured on the second test.

How-

ever, since copulatory stimuli can
influence lordosis in a repeated

testing situation (Hardy & DeBold,
1972), Experiment ? was performed,
to deternine whether copulatory stimuli are
necessary for the
sequential inhibition.
Procedure.

Nineteen ovaxiectomized rats were divided
into

three groups receiving various progesterone treatments
after a 2

EB injection.

Either oil (n=5),

1

2^-

hours

mg (n=9) or 2.5 mg

(n=5) of progesterone was administered at 2k hours,
but animals were

not tested at 30 hours as they were in Experiment 1.

At 48 hours all

animals received 0.5 mg of progesterone and were tested 5-7 hours

later for lordosis (54 hours).
Results and discussion .

i <

Both 1 mg of progesterone U (5,9) =

.05 and 2.5 mg of progesterone, U (5,5) = 0,

^ <

7,

.01, at 24 hours

resulted in a decrease in lordosis when tested at 54 hours (Figure 7).
The results of the last two experiments indicate
ditions of a relatively low dose of EB

(2

that under con-

Mg), progesterone can se-

quentially inhibit the subsequent display of receptive behavior.

It

is clear that copulatory stimuli are neither necessary (Exp^iment 7)

nor sufficient (Experiment 6) for this inhibition.
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Figure ?.

Mean lordosis ratings (+ standard error) of ovari-

ectomized rats injected with oil, 1 or 2.5 mg of progesterone 24
hoxirs after 2 iig of estradiol benzoate.

(Rats were injected with

0.5 mg of progesterone at 48 hours and tested 5-7 hours later.)
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EXPEHDlm

8.

nmBITION

-

IN^ENCE

OF

^BmoiOL

BEHZOATE DCSE

m

Experiment k it was .hown
that concurrent inhibition
Is
critically dependent on the
dose of EB adininistered
.
In Experiment
the
effects
of various doses of EB
8
on sequential inhibition
are
compared.,

£EOceise.

Ovarlectomized rats -ere divided
into two treatment

groups receiving either 6
hours.

^ of EB

(n=6) or 10 ug of EB (n=6)
at 0

At 24 hours all rats were
Injected with

1

mg of progesterone

and tested 5-7 hours later
(30 hours) for sexual receptivity.
'»8

At

hours, all animals received
a O.5 mg progesterone injection
and

were tested. 5-7 hours later for
sequential inhibiticn by the first
progesterone injection. Data ft:om a
group which received 2 Hg of EB
at 0 hours (Experiment 6) axe included,
for comparison.
Hesults and discussion.

£ <

.05,

Both the 6

jig

EB group, u (6,6) =
5,

and the 10 «g EB group U (6,7) =
4.5, £ <

.05, were signi-

ficantly different from the 2 ug EB group,
(Figure 8).

These results

clearly demonstrate that with a sequential
inhibition procedure,
increasing doses of EB can offset the antagonism
of a particular

dose of progesterone just as with concurrent
inhibition.
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Figure 8.

Mean lordosis ratings (+ standard error) of ovari-

ectomized. rats injected with 1 mg of progesterone

2

Aig,

6 ug, or 10 ug of estradiol benzoate.

hours after

Rats were tested

5-7 hours later (30 hour test), administered O.5 mg of progesterone
at 48 hours and tested again 5-7 hour later (54 hour test).
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EXPERIMENT

9:

CONCURRENT INHIBITION

In Experiments 6 and

?, 1

- 30 HO'JR

TEST

mg of progesterone was
successful

in antagonizing sexual behavior
when tested 30 hours later.

In

Experiment 2 which used a concurrent
inhibition procedure, 2.5 mg of
progesterone was necessary to inhibit
2 ;ag of EB.
There are several
obvious differences between these
procedures:
l) In the sequential
inhibition procedure, sexual behavior was
tested 30 hours after progesterone; in the concurrent procedure,
it was tested 48 hours after

the inhibitory progesterone injection.

2) Although plasma estradiol

levels were not measured in these experiments,
in the period after
the sequential progesterone injection, estradiol
levels were probably

lower than after the concurrent progesterone
injection (Cheng &
Johnson, 1974; Tapper, Greig & Brown-Grant,
1974).

the sequential injection, estradiol

had.

3) At the time of

been present in neural tis-

sues for 24 hours; at the time of the concurrent injection,
it was

not yet present.

The purpose of Experiment 9 was to determine whether

1

mg of

progesterone induces a transient inhibition that can be observed

when tested 30 hours after the injection but not after 48 hours.

This

would, perhaps, account for the dose differences in sequential and

concurrent inhibition.

Steroids were injected in a concurrent

procedure and testing occurred at 30 hours rather than at 48 hours
as in Experiment 2.

Procedure .
2

>ig

Twenty-eight ovariectomized rats were injected with

of EB at 0 hours

euid.

received either an injection of

1

mg of

progesterone (n='l4) or the oil vehicle (n«=l4) simultaneously.

At 24

38

hours, all rats received a 0.5 mg
progestero-.e injection and were

tested 5-7 hours later for sexual behavior.

Results and discussion.

The group which received progesterone

concurrently with EB displayed a mean lordosis
rating of I.33 + 0.23;
the oil control exhibited a mean lordosis rating
of I.69 + 0.20.

This difference is not statistically significant,
and the difference
is actually slightly less than that for rats tested
at 48 hours

(Experiment 2).

Experiment 9 was unsuccessful in demonstrating a

transient inhibition with 1 mg of progesterone in a concurrent
in-

hibition procedure when testing occurred, at 30 hours.

However, in

the period after the concurrent injection, estradiol levels were

probably considerably higher than after the sequential injections
(Experiment 6).

Since Experiments 4 and 8 have already demonstrated

the importance of EB dose in both concurrent and sequential inhibition,
it is perhaps not surprising that this dose of progesterone did not

result in inhibition.
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DISCUSSION

These studies offer unequivocal
evidence that progost(
:.erone
antagonizes estradiol's induction of
sexual behavior in ovariectomized
rats using both chronic and single
injections. Although there are
clearly differences between rats and
guinea pigs in the dose of

progesterone required for concurrent inhibition,
the phenomenon
seems to be as robust in rats as in guinea
pigs.

There are at least two obvious reasons
for the previous negative

results of experiments on concurrent inhibition
by progesterone in
ovariectomized rats (Zucker, 1967a).

First, as Experiment 2 demon-

strated, with the dose of EB held constant at
2 Mg, approximately

2»5 mg of progesterone is required, for concurrent inhibition when
tested at HQ hours.

In addition, the inhibition is dependent on the

EB dose as well; six or 10

^

fluence of 5 mg progesterone.
1

EB can offset the antagonistic in-

In earlier work (Zucker, 1967a) only

mg of progesterone with 6 Mg of EB was used.
Perhaps the basis for the species difference in sensitivity to

progesterone is the difference in neural retention between rats and

guinea pigs.

Progesterone is taken up into guinea pig brains in

greater concentrations than in rat brains, and it is retained there
for a longer period of time (Wade et al., 1973).

Experiment 5 was

designed to prevent progesterone levels from rapidly waning.

One

rag

progesterone, which does not significantly inhibit the induction of

lordosis when administered concurrently with 2 wg of EB,
tributed into 5 injections spaced at 4-hour intervals.

wcis

dis-

This treat-

ment resulted in a 45^ decrease in lordosis ratings when tested at
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48 hours, confirming the prediction based on the species difference
in neural progesterone retention.

It suggests that a function of the

higher dose of progesterone necessary for concurrent inhibition in

rats is to maintain progesterone levels at some critical value.

These

results also suggest that the initial levels of progesterone are less
important for the inhibition than is the maintenance dose.

That is,

the low initial dose of progesterone (0.2 mg) resulted in greater
inhibition than the high dose (l mg) when the low levels were maintained for l6 hours by frequent injections.

Sequential inhibition is also as robust a phenomenon in rats
as in guinea pigs.

Just as with concurrent inhibition, species

dissimilarities seem to be dose-dependent.

Rats seem to be less

sensitive to progesterone 's sequentiail inhibitory influence than

guinea pigs.
It is clear that the sequential inhibition measured at 5^ hours
is not a result of copulatory stimuli obtained on the 30-hour test.

Copulatory stimuli are obviously not sufficient for the refractoriness,

because in Experiment 6 all rats received copulatory stimuli but the
sexual behavior of only the 1 mg and 2.5 mg progesterone groups
was inhibited.

In fact, the 0.5 mg progesterone group showed high

levels of receptivity on the30-hour test but was not inhibited when
tested at 54 hours.

Also, the results of Ebcperiment 7 indicate that

copulatory stimuli are not necessary for the inhibition; high doses
of progesterone inhibited sexual behavior tested at 54 hours even

in the absence of the 30-hour test.

Thus, this sequential inhibition

is clearly the result of high doses of progesterone.
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increasing the EB

dose offset t.e sequential
inhibition

resulting f^om a particular
dose of progesterone with
concurrent
inhibition. Thus this inhibition
is dose-dependent. both
on
progesterone and on estradiol.

These results help to explain
the

previous conflicting reports of
progesterone-induced refractory
period

m

ovariectomized rats.

thalamic implants of estradiol

injections of

EB.

1

Previously, Lisk (I969) used hypoand.

Nadler (1970) used two daily

Both of these techniques resulted
in moderate

inhibition by progesterone.

Zucker (1967a). on the other hand,
used

a large (6^) EB priming dose which
did not result in sequential
inhibition.

The results of Experiment 8 are
consistent with the

previous reports

and.

help to explain the basis for the
inconsistencies.

The results of these experiments also
suggest that concurrent
inhibition may not be biochemically distinct
from sequential inhibition.

Although sequential inhibition has been
defined as inhibition that
occurs after estrogen conditioning is complete
(Powers & Moreines.
1976), there is, as yet no reason to assume that in
ovariectomized.

rats, these are anything but procedural distinctions.

of inhibition are dose-dependent on progesterone

and.

Both classes
estradiol.

The

difference seems to be dose-dependent with more progesterone
required for concurrent than sequential inhibition.

This, as already

pointed, out, is likely due to differences in plasma levels
of estra-

diol subsequent to the progesterone injection.
In a concurrent inhibition paradigm, a dose of approximately

2.5 mg progesterone is necessary to inhibit the induction of sexual

receptivity by 2

/Ug

EB.

Experiment 6 demonstrates that as little as

1 mg progesterone injected at 2^ hours can inhibit lordosis sequen-
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tially when tested at

^ ho^^s.

In the concurrent procedure.
48

hours elapse between the inhibitory
progesterone injection
testing; in the sequential procedure,
only 30 hours elapse.

Zucker (1966)

had.

and.

Since

shown in guinea pigs that both
concurrent and

sequential inhibition axe transient.

I

attempted to determine if this

dose difference is due merely to the longer
delay between the inhibitory progesterone injection

and.

testing in the concurrent procedure.

Experiment 9 tested for concurrent inhibition by
1 mg of progesterone

at 30 hours rather than at 48 hours.

This dose of progesterone actu-

ally inhibited slightly less than when tested, at 48
hours.

In the

period following the sequential progesterone injection
(24 hours) the

plasma levels of estradiol were presumably lower than after
the concurrent progesterone injection (O hours; Cheng & Johnson,
1975;

Tapper et al., 1974).

We know that estradiol levels are critically

involved since increasing doses of EB can offset the inhibition by
a

particular dose of progesterone in either the concurrent or sequential

inhibition procedure.

The physiological role of progesterone 's concurrent inhibition
in rats is not known.

Concurrent inhibition may occur during the

estrous cycle of the rat (Barfield & Lisk, 1974; but cf . Powers &
Moreines, 1976).

However, it has been suggested that progesterone 's

inhibitory influences during the estrous cycle should, be sequential,

not concurrent, simply because there are minimal levels of progesterone
in the circulation during estrogen priming in the normal estrous cycle

(Powers & Moreines, 1976).

Although it is instructive to distinguish

between procedures that are designed, to investigate sequential inhibition, the two classes may not be biochemically distinct.
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SECTION II,

S-.IITHETIC

ESTOOGEN ANTAGONIST AS A MODEL OF
INHIBITION

Although progesterone potentiates
estradiol's effects on nestbuilding in ovariectomized mice (Lisk,
1971) and sexual behaviLOT
in rodents (Feder & Marrone, 1977; Morin,
1977), progesterone

'S

Influence on other behaviors is limited to
antagonism of estradiol's
effects.

Progesterone inhibits estradiol's induction of sexual

behavior (Feder & Marrone, 1977; Morin.
1977), running-wheel acti-

vity (Rodier, 1971; Wade, 1976) and maternal behavior (Siegal
&
Rosenblatt, 1975), and estradiol's suppression of eating behavior
(Wade, 1975. 1976).

Recently, evidence has accumulated that the cell nucleus is

the site of action for estradiol's effects on behavior (McEwen,
1975; McEwen, Denef, Gerlach & Plapinger, 197^).

of

After an injection

H-estradiol the greatest concentration of the radioactivity which

accumulates in brain cells is found in purified cell nuclei (Zigmond,
1975; Zigmond & McEwen, 1970).

Inhibitors of transcription (Ho,

Quadagno, Cooke & Gorski, 1973; Hough, Ho, Cooke & Quadagno, 197^;
Quadagno, Shryne & Gorski, 1971; Whalen, Gorzalka, DeBold, Quadagno,

Ho & Hough, 197^) or translation (Quadagno & Ho, 1975) reversibly
inhibit the induction of sexual behavico: when implcinted into the

preoptic area in temporal proximity to

aji

injection of estradiol.

Compelling evidence that the cell nucleus is a site of action
for estradiol derives from work with synthetic estrogen ajitagonists

These are compounds that prevent the full response of a tissue to an
estrogen (Clark, Anderson & Peck, 1973; Katzenellenbogen 4 Ferguson,
1975) •

III

the rat brain, these compounds deplete cytoplasmic
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estrogen receptors (Whalen. Martin
& Olsen, 1975). compete with
estradiol for estrogen receptors
(Whalen et al. 1975). delay
,

replenishment of estrogen receptors
(Whalen et al., I975), inhibit
the uptake of ^H-estradiol into brain
cell nuclei (Chazal, Faudon.
Gogan & Rotsztejn, 1975; Landau.
1977; Luine & McEwen, I977. Luttge,

Gray & Hughes. I976; Roy & Wade,
1977). and displace tritium,
presumably bound ^estradiol from cell
nuclei (Landau, I977. Roy
& Wade, 1977).

Synthetic estrogen antagonists that are
effective in

inhibiting the induction of sexual behavior by
estradiol followed by

progesterone also decrease the uptake and retention
of radioactively
labeled estradiol by cell nuclei of neural target
tissues (Landau,
1976, 1977; Roy & Wade, 1977) offering further support for
a nuclear

site of action.
One possible biochemical mechanism that might account
for the

inhibitory effects of progesterone could be a decrease in cell

nuclear binding of ^H-estradiol in neural estrogen target tissues.
Although, using autoradiography, Anderson and Greenwald (I968) have

reported a decrease in estrogen uptake in hypothalamic cells, pro-

gesterone does not compete

vrith

estradiol for estrogen receptors in

brain or pituitary in vitro (Chader & Villee, 1971; Davies, Siu,

Naftolin & Ryan, 1975; Eisenfeld, 1970; Vertes & King, 1973).

Progesterone also does not inhibit the rate of formation of estrogen-

receptor complexes in pituitary (Korach & Muldoon, 1975), nor inhibit
the replenishment of estrogen receptors in the hypothalajnus or

preoptic area (DeBold, Martin & Whalen, 1976; Pavlik & Coulson,
1976) as in the uterus (Hsueh, Peck & Clark, 1975, 1976).

The synthetic estrogen antagonist CI -628, is one antagonist that
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Inhibits the induction of rat sex^l
behavior (Aral 4 Gorskl, I968,
Powers, 1975i Whalen 4 Gorzalka,
1973) and decreases the binding of

^H-estradlol by brain cell nuclei
(Chazal et

M..

Luttge, Gray 4 Hughes, 1976, Roy 4
Wade, 1977).

1975; Landau, I977

In Section II. an

attempt is n^de to alter cell nuclear
binding of ^H-estradiol through
the use of estrogen antagonists,
progesterone and CI-628, using
sexual behavior as a model.
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EXPERIMENT lOj

EFFECTS OF PROGESTERONE ON R'TENTION
OF ^H-

ESTOADIOL BY BRAIN

CHILL

NUCLEI

With autoradiographic techniques, it
has been reported that

uptake of radioactively labeled estradiol
into hypothalamic cells
can be inhibited by pretreatment with
2.5 mg of progesterone (Anderson

& Greenwald, I969).

The present experiment attempted to alter
re-

tention of estradiol in cell nuclei of neural
areas believed to be
involved in sexual behavior in female rats (Lisk, I969;
Powers, 1972;

Powers & Valenstein, 1972) by pretreatment with a large
quantity of
progesterone.

The biochemical techniques used are identical to those

in which synthetic antiestrogens have been shown to
inhibit the

uptake and retention of "^H-estradiol in brain cell nuclei

(Roy &

Wade, 1977).

Procedure.

Fourteen female rats ovariectomized at least 2 weeks

previously and weighing 250-300 g at the time of sacrifice were used.

Six rats received a 10 mg intraperitoneal injection of progesterone
fO.2 ml) and eight rats received the sesame oil vehicle, followed 2

hours later by an intravenous injection of 100

juCi

(O.3

/dg)

of

2,4,6,7-^H-estradiol-17^(specific activity: 91.3 Ci/mmole; New England
Nuclear, Boston, Mass.) in 20^ ethanol-saline

.

Twelve hours after the

3
-^H-estradiol injection rats were sacrificed as described.

The brain

was dissected into cerebral cortex (120 mg), preoptic area-septum
(60 mg), and hypothalamus (60 mg).

The cortex included frontal and

parietal cortex without white matter; the preoptic area-septum
included the anterior hypothalamus, preoptic area, bed nucleus of the

stria terminalis, and septum.

The hypothalamus was bounded by the
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«a„™inary bodies, hypothalamic
fl.sures and caudal edge of
the optic
Chiasma. extending dorsally
3

The entire pituitary gland
was

also taken.
Results.

The 10

n.g

injectiai of progesterone was
without

effect on the 12-hour retention
of ^-estradiol, (Figure
9).
None of the comparisons of
tissue/plas.a levels of progesterone
vs.
oil groups for the whole
homogenate or nuclear fractions
of the

four tissues approached statistical
significance.

In fact, for all

tissues, tissue/plasma ratios are
quite similar for the two groups.
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Figure 9.

Retention of ^H-estradiol in brain
areas and pituitary

12 hours after an intravenous injection
of 100 ^Ci ^H-estradiol.

Either 10 mg progesterone or oil was
injected intraperitoneally 2
hours prior to estradiol.

(CTX, cerebral cortex; HTH.
hypothalamus;

POA, preoptic area-septumj PIT,
pituitary gland).
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EXPERIMENT 11,

EFFECTS OF ESTOOGEN ANTAGONISTS
ON ^H-ESTRADIOL

BINDING

The results of Experiment 10 gave
no hint of progesterone

inhibition of nuclear retention of
^estradiol.

However, the

\.

estradiol was administered intravenously
and the progesterone intraperitoneally.

In an effort to use a procedure
with more behavioral

relevance, in the next experiment the
steroids were administered in

a manner that is known to result in
behavioral inhibition, that is,

subcutaneously (Section l).

In addition, to optimize the possi-

bility of observing inhibition if it exists,
a very large quantity
of progesterone was injected (lO^-fold excess).

A comparison is also

made with inhibition by an injection of CI-628.
Procedure.

Fifteen rats ovariectomized approximately two weeks

previously and weighing I9O-26O g were used.

Five rats were injected

subcutaneously with 30 mg of progesterone (0.6 ml), five with k
mg
CI-628 (0.6 ml) and five with the sesame oil vehicle
(0.6 ml).
Within seconds, 100 uCi of ^estradiol dissolved in 0.2 ml sesame
oil was injected subcutaneously.

Due to the large volume of the

injections, the progesterone and oil were injected into two separate
sites, each consisting of O.3 ml, and the -^H-estradiol was injected

to a third site.

Four hours later, animals were sacrificed, tissues

dissected, and radioactivity counted as described.

In this experiment,

the hypothalamus and preoptic area sections were pooled and a sample
of midbrain taken (approximately 60 mg), since cannula implants of

progesterone in this area affect receptive behavior (Morin & Feder,
1974c; Ross, Claybaugh, Clemens & Garski, 1971).

The midbrain sample
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was immediately caudal to the hypothalajuus
and included the peri-

aqueductal region of estradiol-concentrating cells described
by

Pfaff and Keiner (1973).
Results and discussion.

As in the previous experiment, compari-

sons of the progesterone vs. oil groups for the whole homogenate

and nuclear fraction of each tissue revealed that the progesterone
treatment was without effect on the uptake of
1).

-^H- estradiol,

(Table

CI-628, however, caused statistically significant inhibition of

cell nuclear binding in hypothalamus, {27%) and pituitary gland (88?^),

but not in cortex or midbrain.

homogenates of all areas.

CI-628 was effective in the whole

These data support the suggestion that

progesterone 's neural mechanism of cuitagonism of estradiol's
influences is not to inhibit the binding of estradiol by brain cell
nuclei
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EXPERH-IENT 12:

SEQUENTIAL INHIBITION BY raCGESTERONE
AND CI-628

The synthetic antiestrogen. CI-628
inhibits the uptake and
retention of ^H-estradiol in hrain

cell nuclei (Roy &Wade. I977.

Exp. 11), whereas even unusually
large doses of progesterone (IO-30

mg) do not (Experiment ll). using
identical techniques.

Progesterone

administered either before or after
estrogen conditioning is complete,
is capable of inhibiting the subsequent
induction of sexual receptivity.

The antiestrogen, CI-628 has been shown
to significantly inhibit

the induction of sexual behavior when
injected approximately concur-

rently with EB (Aral & Gorski, I968; Landau, I976;
Powers, 1975;
Whalen & Gorzalka, 1973).

In Experiment 12 the effects of the syn-

thetic estrogen antagonist, CI-628, and the
natural estrogen antagonist,
progesterone, were compared, by administering each in
a sequential

inhibition procedure.

Each compound was administered after rats had

been screened for lordosis at 30 hours.
Procedure.

Ovariectomized rats were injected with 2 ug of EB

followed 24 hours later by O.5 mg of progesterone and were tested

for lordosis at 29-31 hours.

At this time, only rats in heat were

selected, and. distributed into three closely matched groups, (Fig-

ure 11).

One group (n=5) received 4 mg of CI-628 intraperitoneally

in 0.4 ml saline.

The progesterone group (n=9) received an additional

2 mg of progesterone subcutaneously and the control group (n=5)

received O.5 mg of progesterone and were tested for lordosis 5-7 hours
later (54 hours).

Since some animals showed a high frequency of

rejection of the males, lordosis ratings are based upon five mounts
far each rat.

7^

Results.

Two mg of progesterone after the
first test inhibited

the subsequent induction of sexual
receptivity by a O.5 mg progesterone injection at 48 hours. U
< .05. The CI-628 also
(5.9) = 7.
antagonized the subsequent facilitation
by progesterone at 48 hours,
U (5,5) = 0. 2 < .01 (Figure lO).
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Figure 10.

Mean lordosis ratings (+ standard error) of

ovarlectomlzed rats injected with 2

Jig

of estradiol bonzoato (O hours),

0,5 mg of progesterone (24 hours), tested for sexual receptivity at
approximately 30 hours and Injected with either saline, 4 mg of CI-

628 or 2 mg of progesterone after behavioral testing.
received 0,5 mg of progesterone at
hours later.)

^

(All rats

hours and were retested 5-7

ONIlVd SlSOOdOn

NV31AI

77
EXPERir4ENT 13»

RAPID ANTAGONISM OF SEXUAL BEHAVIOR
BY ESTOOGEN
ANTAGONISTS

The results of Experiment 12 demonstrate
that CI-628 can inhibit
sequentially just as progesterone.

Thus both synthetic and natural

antiestrogens can antagonize receptive behavior
not only in a concurrent inhibition paradigm (Powers,
1975) but also after estrogen

conditioning has been completed.

Feder and Morin (19?^) have shown

that in guinea pigs, the estrogen antagonist, MER-25
is capable of

blocking the inducticn of sexual receptivity when
administered at
about the time of the facilitatory progesterone injection.

In

Experiment 12 the behavioral effects of the two classes of
estrogen
antagonist were dissociated by administering the CI-628 or a large

dose of progesterone near the time of testing.

possibility of detecting inhibition, a dose of
this experiment.

To optimize the
1

yg of EB was used in

Since preliminary data had shown that there is no

effect on lordosis as long as 10 hours after treatment with CI-628,

testing occurred, at 13-1^ hours after treatment.

Procedure .

Fifty ovariectoraized rats were divided into three

groups receiving various treatments 2^ hours after a
injection.

1 jog of EB

Rats were injected with either 0.5 mg of progesterone +

0.4 ml of saline (n=18), 5 mg of progesterone +

OA

ml of saline

(n=ll) or 0.5 mg of progesterone + 4 mg of CI-628 (n=2l) and tested

13-14 hours later for lordosis.

Progesterone was injected subcutane-

ously; the CI-628 (dissolved in 0.4 ml of saline) and saline were

injected intraperitoneally.

Results and discussion .

Addition of the synthetic estrogen
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antagonist inhibited sexual receptivity
tested IJ^lk hours later when
compared, with the group that received
only O.5 mg of progesterone,

U (18,21) = 122.5. £ < .05 (Figure ll).

The group that received

5 mg of progesterone actually displayed higher levels of
lordosis

than the group that received O.5 mg of
progesterone.

These results indicate that administration
of an estrogen
antagonist can decrease receptivity when given at
the time of the

facilitatory progesterone injection and tested

13-1-!^

even a high dose of progesterone at this time cannot.

hour later,

These results

again suggest a different neural mechanism of antagonism
for
gesterone than the synthetic estrogen antagonist, CI-628.

pro--
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Figure 11.

Mean lordosis ratings (+ standard
error) of ovari-

ectomized rats injected with either
0.5 mg of progesterone, 5 mg of

progesterone or 0.5 mg of progesterone +
^ mg of CI-628, 2k hours

after a 1

;ig

of estradiol benzoate injection.

13-14 hours later.)

(Testing occurred
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DISCUSSION

Roy and Wade (197?) have
reported that synthetic estrogen
antagonists that inhibit the
induction of sexual behavior
also decrease the uptake and retention
of ^H-estradiol in brain cell
nuclei.

The results of Experiment
10 demonstrate that there is
no decrease in
retention 12 hours after ^H-estradiol
injections in rats pretreated
with 10 mg of progesterone. This
stands in contrast to results
using synthetic antagonists.
Experiment 11 was performed, to examine
a more behaviorally-relevant mode
of administration of the steroids.

An unusually large dose (30 mg) of
progesterone or 4 mg GI-628 was
administered subcutaneously and concurrently
with a low dose of
estradiol in sesame oil.

\-

Although CI-628 inhibited nuclear binding

in hypothalamus and. pituitary, none
of the progesterone vs. oil

comparisons of k hour uptake approached statistical
significance.

Marrone and Feder (197?) have also failed to
inhibit brain ^Hestradiol uptake in guinea pigs with progesterone
pretreatment.

The

lack of striking inhibition by CI-628 is likely
referrable to its

slow action when administered subcutaneously (Landau,
1977).
Experiments 12 and I3 were designed to contrast behaviorally

the inhibition of sexual receptivity by progesterone and the synthetic antiestrogen, CI-628.

A potent antagonist of estradiol in

the induction of sexual receptivity (Aral & Gorski, I968; Powers,
1975; Roy & Wade, 1977; Whalen & Gorzalka, 1973), CI-628 also in-

hibits the uptake (Chazal et al., 1975; Landau, 1977; Luine & McEwen,
1977; Luttge et al., I976; Roy & Wade, 1977) of

cell nuclei (Roy & Wade, 1977).

^estradiol into

Since large doses of the natural

antiestrogen, progesterone, did not interfere with the uptake
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or retention of ^H-estradiol in hrain cell
nuclei with the same

procedures that were successful with CI-628 (Roy &
Wade, 19??), an attempt was made to dissociate the behavioral effects of
the antagonists
as well.

In Experiment 12, CI-628 or progesterone was
administered

after a test for sexual receptivity at 30 hours.

Both CI-628

and.

progesterone, when administered at 30 hours, inhibited sexual recep-

tivity tested at 54 hours

.

In Experiment I3 the two classes of

antiestrogen were dissociated behaviorally by administering a high

dose of progesterone or CI-628 13-1^1 hours prior to testing.

In

this case only the synthetic antiestrogen inhibited the induction
of sexual receptivity.

Thus, the antiestrogenic influences of

progesterone seem to be dissociable from those of the synthetic
antiestrogens on the behavioral level as well as on the biochemical
level

The results of Experiment I3 are relevant to an interpretation

of estradiol's role in the induction of sexual receptivity.
reports (Bullock, 1970; McEwen, Pfaff

,

Some

Chaptal & Luine, 1975) have

suggested that estradiol has only a triggering function in the in-

duction of sexual receptivity.

That is, it perhaps enters the cell

nucleus (McEwen, 1976; McEwen et al.

,

1975) and stimulates RNA

synthesis (Quadagno, Shryne & Gorski, 1971
Gorski, 1973; Whalen et al., 197^).

«

Terkel, Shryne &

They have suggested that estrar

diol need not be retained for the entire duration of estrogen
conditioning.

In guinea pigs, howerver, the antiestrogen MER-25

is capable of inhibiting sexual behavior when administered at about

the time of the progesterone injection (Feder & Morin, 197^).

In

rats, Whalen and Gorzalka (1973) have demonstrated inhibition when
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01-638

.3

n,ecucn.

aa^nuterea, at various
.„te„.,.

S^^,

,3,

^ ^^^^

^^^^^^^

^^^^^^

aisplacin, bouna 3H.e,,,,,,„,

,y,.,^,^,^ ,,,,
^^^^
wade.
*
1977). demonstrated that
01-628 injected at I3-14
hours
prior to testing can
inhibit sexual behavior.
Landau (1977) has
also demonstrated that CI-628
injected 21 hours after
^H-estradiol
benzoate results in
diminished nuclear
radioactivity 3 hours later
These results offer support
for the interpretation
that conditioning
13 an ongoing process which requires
sustained estrogen presence
(Feder 4 Morin. 197ifj Feder
& Silver. 1974).

SECTION III,

PROGESTERONE- S MECHANISM OF

AC'^'IONi

USE OF A

SYNTHETIC PROGESTIN

Early experiments that investigated a nuclear site of action
for progesterone or binding of progesterone to cytoplasmic
receptors

in the mammalian uterus were hampered by the technical limitations
inherent in studying a relatively weak interaction of a hormone with
its receptor.

steroid

17<<,

Along with other recent technical advances, the
21-dimethyl-19-nor-pregna-4,9-diene-3,20-dione

has been synthesized.

(R 5020)

This synthetic progestin bi:.ds specifically

to progestin receptors with high affinity and dissociates less

rapidly than progesterone itself (Philibert & Raynaud, 1973; 197^).
In uterine cytosol it binds to receptors with an

constant 2-5 times that of progesterone.

association

It binds to the same number

of sites as progesterone supporting the notion that it binds only

to progestin receptors (Philibert & Raynaud, 1973; 197^; Walters &
Clark, 1976).

R 5020 is physiologically quite active, 200-300 times

as active as progesterone in standard uterine bioassays for progestins
(Philibert & Raynaud, 1973), a fact consistent with its higher affinity
for progestin receptors.

The unique binding characteristics of R 5020

have proven useful in characterizing the binding of progestins to
cytoplasmic receptors in tumorous and reproductive tissues of various

species (McGuire, Raynaud & Baulieu, 1977).

On the basis of experiments which have investigated binding-

activity relationships of steroid hormones (Raynaud, 1977). it can
be Inferred that if binding is involved in behavioral responses, then

a progestin that binds to progestin receptors with higher affinity
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than progesterone should be more
active in affecting sexual behavior.
The activity of R 5020 in facilitating
and inhibiting sexual behavior
is tested in Experiments 14 and
15
In the final two experiments,
.

nuclear binding of

Vr

that of -^-progesterone.

5020 is investigated and contrasted with
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EXPERIMENT 14,

FACILITATION AND SEQUENTIAL INHIBITION
BY R 5020 COMPARISON WITH PROGESTERONE

The purpose of Experiment 14
is to determine the relative
ef-

fectiveness of R 5020 compared with
progesterone in the facilitation
and sequential inhibition of female
sexual behavior.

Procedure.
ten groups.

Ninety-two ovariectomized rats were divided
into

All rats received 2 Mg of EB at 0
hours.

they received either oil (n=13).
R 5020 (n=10), 5

25

;ig

^

1 Aog of R 5020 (n=5),

of R 5020 (n=ll). 10

of R 5020 (n=10), 100

jug

^

At 24 hours,
2.5

;ag

of

of R 5020 (n=8),

of progesterone (n=10). 250

^g of

progesterone (n=8), 500

;ag

of progesterone (n=8).

Five to seven hours later (30 hours), rats

of progesterone (n=10), or 1,000 ng

were tested for sexual receptivity.

At 48 hours, all rats were

administered O.5 mg of progesterone and tested five to seven
hours
later (54 hours).
Results.

As little as 5

;ag

of R 5020 significantly facilitated

sexual behavior at 30 hours when compared with oil controls, U
(11,13)
= 7.5.

= 17,

2 <
_B

<

'002,
.02,

compared with 250

needed for progesterone, U (8,13)

(Figure 12).

As low a dose as 10 ^g of R 5020 sequentially inhibited sexual
behavior at 30 hours, U (8,13) = 24, ^ < 'OS. compared with 1,000
iig

needed for progesterone, U (7,13) = 6.5, 2 < -002, (Figure 12).
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Figure 12.

Mean lordosis ratings of ovariectomized
rats

injected with various doses of R 5020 (top panel)
or progesterone
(bottom panel), or sesame oil vehicle 24 hours
after 2

estradiol benzoate.
facilitation).

xig

of

Rats were tested 5-7 hours later (30 hour test-

All rats received O.5 mg of progesterone at 48
hours

and were tested again 5-? hours later (54 hour
test-inhibition).
(All steroids were dissolved in 0.1 ml of sesame oil
and were

injected subcutaneously.)

FACILITATION AND SEQUENTIAL INHIBITION OF
SEXUAL BEHAVIOR BY R 5020 & PROGESTERONE

mmmm

15,

concument inhibition by r
5020 - comparison wi™
PROGESTERONE

The purpose of Experiment I5
is to further characterize
R 5020 's
inhibitory effects by investlgati,^
its relative effectiveness
in
concurrent inhibition.
^:ocedis:e.

Forty-eight ovariectomized rats were
divided into

eight groups receiving various
doses of R 5020, progesterone or
oil

concurrently with EB.

1^0
10

hours.

iig

1.000

All rats were injected with 2
^g of EB at

At this time either oil (n=6),
5

of R 5020 (n=6),

of R 5020 (n=6), 25 Mg of R 5020 (n=6),
50

^

of progesterone (n=6), 2,500

)xg

;ug

of R 5020 (n=6),

of progesterone (n=6). or

5,000 ng of progesterone (n=6) were injected at a
separate subcutaneous site.

Forty-two hours later (0800 hours), 0.5

rag

of

progesterone were administered, and sexual receptivity
was tested
five to seven hours later.

Results and discussion .

As little as 50

/Ug

of R 5020 inhibited

sexual behavior compared with oil controls, U (6,6) =
^, ^ < .05,

(Figure 13).
U (6.6) = 1,

2,500

2 <

jug

of progesterone were required for inhibition,

.005 (Figure I3).

Thus, R 5020 is 5O-IOO times more effective than progesterone

as both a facilitator and inhibitior of sexual behavior.

This

lends support to the hypothesis that progestins' effects on behavior

are mediated by a receptor mechanism as uterine effects may be.
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Figure I3.

Mean lordosis ratings of ovariectomized rats in-

jected with various doses of R 5020, progesterone
or sesame oil

vehicle simultaneously with 2

;ag

of estradiol benzoate.

All rats

received O.5 mg of progesterone at kZ hours and were tested at

approximately 48 hours.

(All steroids were dissolved in 0.1 ml of

sesajne oil and were injected subcutaneously.
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RATS

As previously aisoussed,

R JOZO's unique

Mnding characteristics
have .aae It a useful tool
In the study of uterine
progestin receptors
Experiments 14 and I5 are
consistent with the
interpretation that
progestins' behavioral effects
axe receptor-mediated. In
this experiment, an attempt is made
to observe binding by
brain cell nuclei.
using ^H-R 5020.

^ocedi^e.

Female Spr ague-Da wley rats
weighing 150-220 grams
were ovariectomized and
adrenalectomized and injected daily
^^th 2
of EB for six to eight days.
To determine the effects of
estrogen
priming, EB was omitted in one
group (unprimed; n=4), and the
rats
received sesame oil vehicle injections.
To demonstrate saturability

^

and progestin-specificity of the
binding, primed rats were injected

mtraperitoneally with

1

mg of unlabelled R 5020 (n=4),
progesterone

(n=4), corticosterone (n=5),
testosterone (n=k)

vehicle (n=6), 75 minutes prior to
sacrifice.

,

or the ethanol

Sixty minutes prior to

sacrifice, all rats were injected intravenously
with 20 uCi 6,7

\-

R 5020 (0.1 pg. specific activity =
56.5 Ci/mmole) dissolved in

20fo

ethanol-saline.

'

Pituitary gland, cerebral cortex, preoptic
area-

septum and hypothalamus described previously were
then dissected.

The sample of midbrain (70 mg) which extended
3 mm caudal to the
hypothalamic sample was bordered dorsally by the
posterior commissure

and vertically by the pons.

Uterus (120 mg) was minced, homogenized

in a ground glass homogenizer, and filtered through two
layers of

gauze
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Results.

The pattern of uptake in
whole homogenates of the

estrogen-pri.ed rats was uterus >
pituitary > midbrain > hypothalamus
- preoptic area-septum > cortex. Neither
estrogen priming nor com-

peting steroids had any effect on
whole homogenate uptake in neural
tissues. However, estrogen priming
doubled uptake in uterus and
quadrupled uptake in pituitary.

Either R 5020 or progesterone pre-

treatment in estrogen-primed rats decreased
whole homogenate uptake
in uterus and pituitary by
59-89f..

Testosterone and corticosterone

were less effective competitors than the
two progestins.

The pattern of binding in cell nuclei was
considerably different
from whole homogenates, probably owing to the
extensive amount of
nonspecific, nonsaturable uptake of progestins in
whole homogenates
of neural tissues:

uterus > pituitary > hypothalamus > preoptic
area-

septum = cortex > midbrain (Fig. Ik).

Omission of estrogen priming

resulted in an approximately 8^% decrease in nuclear binding by
hypothalamus, preoptic area-septum, uterus and pituitary, a small

decrease in cortex, but no statistically significant charge in midbrain,

R 5020 pretreatment suppressed nuclear binding in hypothalamus,

preoptic area-septum, pituitary and uterus to approximately the
levels of unprimed rats.

5020 as a competitor.

Progesterone was nearly as effective as R

Both progestins were significantly more ef-

fective competitors than either testosterone or corticosterone.

The

competition that was obtained with testosterone and corticosterone
is likely due to having used, a very large dose of competitor (l mg)

compared with the

-^H-R

5020 (0,1

iJg),

9^

Figure 14.

Binding of

-'H-R

5020 or its metabolites in brain,

pituitary, and uterine cell nuclei of ovariectomized-adrenal-

ectomized female rats one hour after intravenous injection of 20
juCi of ^H-R 5020,

Controls (n=6) received daily injections of 2 ug

of estradiol benzoate for 6-8 days as did the groups which received
1 mg of R 5020 (n=4), progesterone (n=4), corticosterone (n=5) or

testosterone (n=4) 75 minutes prior to sacrifice.
(n=4) received daily oil injections.

Unprimed rats

Results are expressed as

tissue/plasma ratios of DPM/mg protein:

DPM/jil plasma.

vwsvid/3nssii
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EXPERIMENT 1?.

^PROGESTERONE UPTAKE IN OVARIECTOMIZED-ADRENALECTOMIZED, ESTROGEN-PRIMED RATS

Although previous experiments in guinea
pigs (Marrone & Feder,
1977) and rats (McEwen et al., I976) have failed
to detect nuclear

binding of ^H-progesterone using liquid
scintillation counting
techniques, none of these experiments have
used identical procedures

to those which were used in Experiment 16.

Experiment 1? is an

attempt to verify either the presence or absence
of radioactivity in
brain cell nuclei after injection of ^H-progesteror.e.
Procedure.

The procedure is the same as that followed in

Experiment I6 except that rats were injected with 1,2-^H-progesterone
(Specific activity = 55.7 Ci/mmole; New England Nuclear).

One

group (n=6) received the ethanol vehicle 75 minutes prior to sacrifice
and one group received 1 mg of unlabelled progesterone (n=4).

Results.

The small amount of radioactivity that was found in

cell nuclear fractions was not saturable as evidenced by the failure
of 1 mg of progesterone to compete for binding (Table II).

In whole

homogenates, only the uterus specifically accumulated radioactivity

evidenced by a decrease in uptake after pretreatment with unlabelled
progesterone.
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DISCUSSION

H 502C 13 the first
progestin reportea to be
.ore effective
than progesterone as
both a facilitator
and Inhibitor
of sexual

behavior.

Horprogesterone which is
also a 19-norprogestin
is 20
tl»es .ore effective than
progesterone In facilitating
sexual behavior
fe^le guinea pigs (Kind.
1964). Medroxyprogesterone
(><-„ethyl-

m

W-acetoxypre6n-4-ene-3.20-dlone) is
several ti.es .ore effective
than progesterone in
facilitating sexual behavior
In female rats
(Meyerson, I967). Neither
of these steroids has
been tested for
inhibitory effects.

The biochemical experiments
represent the first report of
nuclear
binding Of a p-ogestln In rat
tealn. although binding
has been reported in guinea pigs' brains
using autoradlc^aphy (Sar 4
Stumpf,
Taken as a whole, the behavioral
experiments and the biochemical experiments are quite
consistent with each other and
with the
1973).

hypothesis that brain cell nuclear
binding is Involved in behavioral

responses to progestins.
There is, of course, an alternative
explanation for the effective-

ness of R 5020 on sexual behavior.

Slowed rate of metabolism of the

synthetic progestin, medroxyprogesterone
acetate, has already been
suggested as the basis of its hypereffectiveness
in uterine res-

ponses (Feil, Miljkovic A Bardin,
1976).

Although this explanation

cannot be overlooked, we also cannot overlook
the fact that R 5020 is
50 times more effective than progesterone at a very short
time after

Injection (i.e. facilitation of sexual behavior
5-? hours after
injection).

It is. however, not unlikely that a combination
of factors

Is Involved in R 5020 's increased potency.
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The high concentration of ^H-R
502O binding by pituitary cell
nuclei, though probably not
relevant to behavior, is pertinent
to an
understanding of progesterone 's
influences on reproductive physiology.
That is. the pituitary is believed
to be one site of action for

progesterone 's effects on gonadotropin
release (Barraclough. I973.

Feder & Maxrone. 1977; Schally, Arimura
& Kastin, 1973).

Similarly,

the high concentration in the hypothalamus
is consistent with the

results of cannula implant studies, which
have demonstrated that
the hypothalamus is one site of action
for progesterone 's facilition
of rat (Powers, 1972; Ross et al., I97I; Ward
et al., 1975) and

guinea pig (Morin & Feder, 1974b) sexual behavior.

The hypothalamus

also seems to be a site of action for progesterone
's inhibition of

rat sexual

behr-.vior

(Marrone & Feder, personal communication).

The lack of binding in the midbrain is quite puzzling since

cannula implant studies have consistently found the midbrain to
be
one site of action for progesterone 's effects on sexual behavior.

Unfortunately, the direction of the results are conflicting.

In

guinea pigs (Morin & Feder, 1974c), hamsters (DeBold et al., I976) and

rats (Yanase & Gorski, 1976), the midbrain is reported to be a
site of inhibition of sexual behavior.

Conversely, Ross et al.,

(1971) and Luttge and Gughes (1976) have reported facilitation of rat

sexual behavior with progesterone implants in the midbrain reticular

formation and interpeduncular nucleus, respectively.

Unfortunately,

until the gross interlaboratory and potential interspecies differences
in the anatomical localization of progesterone 's effects are reconciled, it cannot be inferred from implant data that nuclear binding
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is involved, in only facilitation
or only inhibition.

Nevertheless, implants of progesterone
in the midbrain affect sexual
behavior.
saturable, nuclear binding of R
5020 could not be observed in
this
area. Either the procedures
used do not afford sufficient
resolution
to observe what may be very low
concentration of binding or alter-

natively, progestins may have a
different subcellular site of action

in this area, perhaps at the neuronal
synapse (Janowsky & Davis. I976).
Finally, the dependence of the progestin
binding on estrogen

priming is quite exciting.

It is of course consistent with
the

dependence on estrogen priming for the synthesis
of progestin

receptors (Faber, Sandmann & Stavely, 1972a,
1972b; Freifeld, Fell &
Bardin. 197^; Leavitt et al.

.

1974j Milgrom. Atger & Baulieu, I97O;

Luu Thi. Baulieu & Milgrom. 1975) and uptake of
^H-progesterone in
peripheral tissues (Chen & Leavitt, I975. Falk & Bardin,
I97O;

Leavitt & Blaha. 1972), as well as for progesterone' s
facilitation
of behavior (Feder & Marrone, 1977? Marin,
1977).

These results

also suggest that estrogen and progesterone may act on the same
cells
in progestin-responsive neural tissues.
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GENERAL DISCUSSION

Section I demonstrated that with
appropriate doses, progesterone
can inhibit sexual receptivity in
rats in both a concurrent and

sequential inhibition procedure.

These experiments raise a number of

interesting questions concerning progesterone
's role in the modulation
of sexual receptivity.

Inhibition of sexual behavior in rats requires
approximately 1
-

2.5 mg of progesterone compared to less than

guinea pigs in similar,
1975; Zucker, I966).

required in rats?

1

mg required for

but not identical procedures (Wallen et al.

What is the basis for the elevated levels

Experiment 5 addressed this question by demonstrat-

ing that 1 mg of progesterone, which did not inhibit concurrently
when injected simultaneously with EB, was effective when divided

into five repeated injections over a period of 16 hours.

The

results are consistent with the notion that maintained neural levels
of progesterone may be necessary for inhibition.

They are also

consistent with an interpretation that blood plasma levels must be

maintained at a sufficiently elevated level, or that a sustained

supply of unmetabolized progesterone must be maintained.

The

species difference could be due to shorter retention of progesterone
in the brain or plasma or the rapid metabolism in rats.

The fact that the same types of dose relationships held for
concurrent inhibition as sequential inhibition suggest that these

two clsLSses of inhibition may be essentially the same phenomenon.
Nevertheless, we are left to explain the fact that concurrent inhi-

bition requires 2.5 mg of progesterone^ but sequential inhibition
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requires only 1 mg of progesterone.

Experiment 9 demonstrated that

the shorter interval between progesterone
injection and testing

i;.

the sequential inhibition procedure is probably
not responsible.

It

remains to be explained why less progesterone
is required to
inhibit sequentially than is required to inhibit
concurrently.

At

the time of the progesterone injection in concurrent
inhibition,

plasma estrogen levels are their highest, but
conditioning has just
begun.

The solution to the problem will likely require a
prior

understanding of what estrogen conditioning is at a
neurochemical
level.

Progesterone requires estrogen priming in order to facilitate
sexual behavior.

The higher the estrogen dose, the lower the dose

of progesterone needed to facilitate (Whalen, 1974).

Why then,

does increasing the priming dose of estradiol decrease responsivity

to progesterone 's inhibitory influences?

This suggests that the

dose required for facilitation is dose-dependent on estradiol but the
dose required for inhibition is inversely related to the dose of
estradiol.

Does this imply that progesterone 's facilitatory and

inhibitory effects are mediated by distinct neurochemical mechanisms
with differing dependence on estradiol?

A mechanism of action for progesterone must be able to resolve
all of these questions, as well as account for the results of a

recent experiment by Marrone, Rodriguez-Sierra and Feder (197?)
which suggested that progesterone 's inhibitory effects can occur
with as short a latency as the facilitatory effects.

When the heat

duration of rats was extended by injecting a large dose of progester-
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one, heat could be terminated vdthin four ho^rrs ty a second
dose of

progesterone.

Facilitation can occir in less than an hour of ad-

ministration when injected intravenously (Lisk, I96O; Meyerson,
1972).
It has yet to be seen whether inhibition can occur quite this rapidly.

Section II offers evidence that progesterone does not inhibit
sexual behavior by the same mechanism as the synthetic estrogen
Eintagonists .

With two conflicting reports (Anderson & Greenwald,

1969; Ciaccio & Lisk, 1972) progesterone does not diminish whole

homogenate or cell nuclear binding of estradiol in the brain of any

rodent species that has been studied.

Progesterone does not affect

estradiol's interaction with the estrogen receptor, nor affect the

replenishment of the estrogen receptor in the

hypothalamus.

Conversely, synthetic estrogen antagonists are effective in inhibiting

each of these steps.

The behavioral effects of progesterone and the

synthetic estrogen ajitagonist, CI-628, are dissociable behaviorally
as well; CI-628 shortens heat duration, and increasing progesterone

doses actually lengthen it.
Recently, the suggestion has been made that lengthy progesterone
3
pretreatment may actually increase in vivo -^H-estradiol uptake in

preoptic area, hypothalamus and pituitary and in vitro nuclear
"binding of -^H-estradiol in the hypothalamus and pituitary (Reuter &

Lisk, 1976).

These results are difficult to interpret since, on

the basis of current: hypotheses of estrogen's mechanism of action,
one would predict from these results that progesterone pretreatment
would increase responsiveness to estrogen, which it does not.

Although Section II only demonstrated a mechanism by which
progesterone probably does not affect sexual behavior. Section III

.
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has proposed a testable
hypothesis of how it migh affect
sexual
behavior. As already discussed,
the cell nuclear binding of
a
progestin. 3h.r 302O is estrogen
dependent, lending credence to
the
hypothesis that the "two-step" mechanism
of steroid action may be
involved in progesterone 's effects
on sexual behavior. The speci-

ficity with which R 5020 binds to
progestin receptors allows the

results of ^h-R 502O binding studies
to be generalized to progesterone
itself (Raynaud. 197?)
The rapidity with which progesterone 's
facilitatory andinhibi-

tory actions occur is perhaps the most
troublesome argument against
a cell nuclear site of action.

Although we are accustomed to thinking

that an effect of a steroid hormone on sexual
behavior involving

genetic expression would require many hours to
exert itself (McEwen,
1976; McEwen et al.. 1975), this need not be the case.

Early events

of estrogen's action in the uterus occur within
a few hours (Anderson,

Peck & Clark. 1975).

Certainly the "induced protein" is detectable

within an hour of estrogen administration (Barnea & Gorski. I970).
We need, only postulate that early products of progesterone 's
effects on genetic expression are involved in progesterone 's facili-

tation and/or inhibition of sexual behavior.

It should be emphasized

that a proposed nuclear site of action for progesterone in no way

precludes effects on the cell membrane (Marrone & Feder. 1977), either
independent of, or secondary to the nuclear mechanism.
This dissertation could hardly be considered complete without
at least

scaae

speculations as to the biological significance, if any,

of progesterone 's effects on sexual behavior in rats.

Joslyn, Feder

and Goy (1971) have suggested that the function of the synergistic
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•

action of progesterone in female rodents may be for estrous
behavior

and ovulation to become "temporally bound to each other in the
normal
cycle...."

An inseparable link between sexual receptivity and

ovulation is an association with obvious adaptive significance.

Progesterone sequentially inhibits sexual behavior in ovariectomized rats, as endogenous progesterone may during the estrous
cycle.

During the estrous cycle, it would seem likely that the

progesterone-induced sequential inhibition may more firmly link
sexual receptivity with ovulation by opening and then closing a

discrete window of time during which both may occur.

Progesterone concurrently inhibits in ovariectomized rats, and

may contribute to the absence of sexual behavior during pregnancy
(Hardy, 1970).

Following copulation, there ensues an immediate

postcopulatory period of inhibition (Hardy & DeBold, 1972) and an
elevation of progesterone levels in blood plasma within six hours
(Adler, Resko & Goy, 1970).

Perhaps concurrent inhibition by

progesterone is a mechanism that operates as a continuation of
the neural inhibition of sexual receptivity that has been described.
(Lodder & Zeilmaker, 1976).
Lastly, it must be pointed out that progesterone 's effects on

sexual behavior should not be dismissed as
of laboratory rodents.

of sexual behavior

.in

sin

interesting artifact

Progesterone antagonizes estrogen's induction
guinea pigs, hamsters, rats (Feder & Marrone,

1977; Morin, 1977; Young, I969), mice (Edwards, 1970), rabbits (Beyer,

Vidal & McDonald, I969), sheep and goats (Phillips, Fraps and Frank,
19^5), swine (Day, Anderson, Hazel

& Shelton, I969).

Sc

Melampy, 1959) and cows (Carrick

Thus, even if it may not be a universal principle,

progesterone *s inhibition of sexual behavior is certainly widespread.
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